ClearSign Technologies Corporation Provides Third Quarter 2024 Update
Company Achieves Record Quarterly Revenue of $1.85MM
TULSA, Okla., Nov. 20, 2024 /PRNewswire/ — ClearSign Technologies Corporation CLIR (“ClearSign” or the “Company”), an emerging an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational and energy efficiency, enable the use of hydrogen as a fuel and enhance safety while dramatically reducing emissions, today provides an update on operations for the quarter ended September 30, 2024.
“We are happy to report a record revenue quarter of almost two million dollars,” said Jim Deller, Ph.D., Chief Executive Officer of ClearSign. “We are very encouraged by our growing pipeline of projects to be shipped, installed and in engineering phases. Our sales channels are expanding through a network of partners, OEM’s and engineering firms, and we believe this is an integral part of expanding our sales operation. From our installed base to third-party testing like the California GET program, our operational performance continues to provide additional compelling data for our products and supports our reputation as a solution provider,” concluded Dr. Deller.
Recent strategic and operational highlights during, and subsequent to, the end of the third quarter 2024 include:
Reported Record Quarterly Revenue: For the third quarter of 2024, the Company recognized approximately $1.85 million in revenues compared to $85 thousand for the comparable period in 2023. The year-over-year increase in revenues was driven predominantly by the shipment of an order for 20 process burners to a California refinery customer.
Announced Flare Order for Energy Company in California: The order from a prior flare customer is for the initial engineering for a flare retrofit to be installed at a production facility. The final product is expected to be fabricated and shipped in the second quarter of 2025 and to be installed at the customer’s site in the San Joaquin Valley of California.
Announced Public Release of California Statewide Gas Emerging Technologies (GET) Report on Boiler Burners: The study, sponsored by Southern California Gas Company (“SoCalGas”), was to test and quantify the emissions improvements and efficiency gains for the ClearSign Core™-Rogue ultra-low NOx boiler burner compared to a conventional (or baseline) ultra-low-NOx burner operating in the same boiler. Specifically, the report concluded that the ClearSign ultra-low NOx burner demonstrates material savings for fuel and electricity while producing ultra-low NOx levels and was capable of NOx levels lower than the baseline burner.
Announced Burner Orders for Power Generation Customers in Oklahoma and Missouri: ClearSign has received two burner orders approximately a month apart from Exotherm Corporation of Houston, Texas (“Exotherm”). The first burner order was for installation in a heater in Oklahoma for use by a power generation company. The second burner order is from a different power generation company for installation and use in Missouri.
Announced Order for Multi Heater Project for Texas Petrochemical Facility: The Company received the initial engineering order from engineering and heater manufacturer Birwelco USA Inc. (a BIH Group company) as the first phase of a project to retrofit four process heaters with a total of 26 ClearSign Core™ burners to be installed in the Gulf Coast facility of a Fortune 500 global chemical company.
Cash and cash equivalents were approximately $14.5 million as of September 30, 2024.
There were 50,234,407 shares of the Company’s common stock issued and outstanding as of September 30, 2024.
The Company will be hosting a call at 5:00 PM ET today. Investors interested in participating on the live call can dial 1-800-836-8184 within the U.S. or 1-646-357-8785 from abroad. Investors can also access the call online through a listen-only webcast at https://app.webinar.net/4grpJ5DdkyV or on the investor relations section of the Company’s website at http://ir.clearsign.com/overview.
The webcast will be archived on the Company’s investor relations website for at least 90 days and a telephonic playback of the conference call will be available by calling 1-888-660-6345 within the U.S. or 1-646-517-4150 from abroad. Conference ID #65937. The telephonic playback will be available for 7 days after the conference call.
About ClearSign Technologies Corporation
ClearSign Technologies Corporation designs and develops products and technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, the use of hydrogen as a fuel and overall cost-effectiveness. Our patented technologies, embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit www.clearsign.com.
Cautionary note on forward-looking statements
All statements in this press release that are not based on historical fact are “forward-looking statements.” You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may,” “will” or other similar expressions. While management has based any forward-looking statements included in this press release on its current expectations on the Company’s strategy, plans, intentions, performance, or future occurrences or results, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, that could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not limited to, the Company’s ability to successfully deliver, install, and meet the performance obligations of the Company’s burners in the California and Texas market, and any other markets the Company may sell products in; the performance of the Company’s products, including its ultra-low NOx burner and the related fuel and electricity savings; the Company’s ability to timely fabricate and ship its burners; the Company’s ability to further expand the sale of ultra-low NOx process and boiler burners; the Company’s ability to successfully perform engineering orders; the Company’s ability to successfully develop the 100% hydrogen burner with the Phase 2 grant funding; general business and economic conditions; the performance of management and the Company’s employees; the Company’s ability to obtain financing, when needed; the Company’s ability to compete with competitors; whether the Company’s technology will be accepted and adopted and other factors identified in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and other factors that are detailed in the Company’s periodic and current reports available for review at www.sec.gov. Furthermore, the Company operates in a competitive environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and, except as may be required by law, undertakes no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which the Company hereafter become aware.
ClearSign Technologies Corporation and Subsidiary Condensed Consolidated Balance Sheets (Unaudited) |
||||||
(in thousands, except share and per share data) |
September 30, |
December 31, |
||||
2024 |
2023 |
|||||
ASSETS |
||||||
Current Assets: |
||||||
Cash and cash equivalents |
$ |
14,486 |
$ |
5,684 |
||
Accounts receivable |
749 |
287 |
||||
Contract assets |
149 |
188 |
||||
Prepaid expenses and other assets |
610 |
350 |
||||
Total current assets |
15,994 |
6,509 |
||||
Fixed assets, net |
245 |
275 |
||||
Patents and other intangible assets, net |
855 |
836 |
||||
Total Assets |
$ |
17,094 |
$ |
7,620 |
||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||
Current Liabilities: |
||||||
Accounts payable and accrued liabilities |
$ |
1,486 |
$ |
366 |
||
Current portion of lease liabilities |
82 |
71 |
||||
Accrued compensation and related taxes |
401 |
703 |
||||
Contract liabilities |
174 |
1,116 |
||||
Total current liabilities |
2,143 |
2,256 |
||||
Long Term Liabilities: |
||||||
Long term lease liabilities |
128 |
172 |
||||
Total liabilities |
2,271 |
2,428 |
||||
Commitments and contingencies (Note 9) |
||||||
Stockholders’ Equity: |
||||||
Preferred stock, $0.0001 par value, zero shares issued and outstanding |
— |
— |
||||
Common stock, $0.0001 par value, 50,234,407 and 38,687,061 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively |
5 |
4 |
||||
Additional paid-in capital |
112,686 |
98,922 |
||||
Accumulated other comprehensive loss |
(16) |
(17) |
||||
Accumulated deficit |
(97,852) |
(93,717) |
||||
Total stockholders’ equity |
14,823 |
5,192 |
||||
Total Liabilities and Stockholders’ Equity |
$ |
17,094 |
$ |
7,620 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
ClearSign Technologies Corporation and Subsidiary Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) |
||||||||||||
(in thousands, except share and per share data) |
For the Three Months Ended |
For the Nine Months Ended |
||||||||||
September 30, |
September 30, |
|||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||
Revenues |
$ |
1,859 |
$ |
85 |
$ |
3,006 |
$ |
1,129 |
||||
Cost of goods sold |
1,308 |
61 |
1,976 |
870 |
||||||||
Gross profit |
551 |
24 |
1,030 |
259 |
||||||||
Operating expenses: |
||||||||||||
Research and development |
329 |
93 |
1,012 |
440 |
||||||||
General and administrative |
1,655 |
1,428 |
4,840 |
4,649 |
||||||||
Total operating expenses |
1,984 |
1,521 |
5,852 |
5,089 |
||||||||
Loss from operations |
(1,433) |
(1,497) |
(4,822) |
(4,830) |
||||||||
Other income, net |
||||||||||||
Interest income |
146 |
85 |
284 |
237 |
||||||||
Government assistance |
131 |
38 |
395 |
145 |
||||||||
Gain from sale of assets |
— |
— |
— |
5 |
||||||||
Other income, net |
1 |
42 |
8 |
204 |
||||||||
Total other income, net |
278 |
165 |
687 |
591 |
||||||||
Net loss |
$ |
(1,155) |
$ |
(1,332) |
$ |
(4,135) |
$ |
(4,239) |
||||
Net loss per share – basic and fully diluted |
$ |
(0.02) |
$ |
(0.03) |
$ |
(0.09) |
$ |
(0.11) |
||||
Weighted average number of shares outstanding – basic and fully diluted |
54,714,910 |
38,562,127 |
46,986,914 |
38,459,313 |
||||||||
Comprehensive loss |
||||||||||||
Net loss |
$ |
(1,155) |
$ |
(1,332) |
$ |
(4,135) |
$ |
(4,239) |
||||
Foreign-exchange translation adjustments, net of taxes |
5 |
(1) |
1 |
(13) |
||||||||
Comprehensive loss |
$ |
(1,150) |
$ |
(1,333) |
$ |
(4,134) |
$ |
(4,252) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/clearsign-technologies-corporation-provides-third-quarter-2024-update-302311973.html
SOURCE ClearSign Technologies Corporation
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Nvidia Stock Holding Up Better Than Gary Black's Expectations Amid Blackwell Chip Delays And Q4 Whisper Number Miss: Here's Why
Gary Black believes Nvidia Corporation’s NVDA stock remains resilient despite production delays for its Blackwell chips and missing fourth-quarter whisper numbers.
What Happened: On Wednesday, Black, managing partner of The Future Fund, took to X, formerly Twitter, and said that Nvidia’s Blackwell chips are ramping up a few months later than expected.
The company also missed fourth-quarter whisper numbers — which reflected higher investor expectations than official forecasts.
Despite this, Nvidia’s management assured that demand for its chips will exceed supply through 2025, indicating strong growth prospects.
See Also: Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
He also highlighted Nvidia CFO Colette Kress addressing concerns about gross margins, forecasting a start in the low 70% range during the first half of 2025, gradually increasing to mid-70% as Blackwell chip production stabilizes.
Nvidia’s near-term hurdles, including delayed chip rollouts and margin pressures, are balanced by unprecedented demand in the AI and data center markets.
Black remains optimistic, stating that Nvidia’s stock is likely to “shake off” the fourth-quarter whisper miss and reach new highs due to its dominant position in the semiconductor industry.
Why It’s Important: On Wednesday, Nvidia also reported third-quarter revenue of $35.1 billion, a 94% increase year-over-year, surpassing the Street consensus estimate of $33.12 billion, according to data from Benzinga Pro.
The Jensen Huang-led AI chip giant projected fourth-quarter revenue to be about $37.5 billion, with a margin of error of 2%.
The company also announced that production shipments for its Blackwell chips are set to start in the fourth quarter of 2025, with scaling expected to continue into fiscal 2026.
In September 2024, Beth Kindig, lead tech analyst at I/O Fund, predicted that Nvidia could achieve a $10 trillion valuation, with the Blackwell chips anticipated to drive the company to deliver “fireworks again” in 2025.
However, historically, December has been a difficult month for Nvidia investors. Seasonal trends indicate that the semiconductor leader frequently experiences a short-term bearish period after releasing its third-quarter earnings report.
Price Action: Nvidia shares fell 0.76% on Wednesday, closing at $145.89, and dropped an additional 2.53% in after-hours trading, reaching $142.20 at the time of writing.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Universal Technical Institute Reports Fiscal Year 2024 Fourth Quarter and Year-End Results
PHOENIX, Nov. 20, 2024 /PRNewswire/ — Universal Technical Institute, Inc. UTI, a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2024 fourth quarter and the full year ended September 30, 2024. Universal Technical Institute, Inc. operates in two reportable segments, Universal Technical Institute (UTI) and Concorde Career Colleges (Concorde), and together with its segments and subsidiaries is referred to as the “Company,” “we,” “us” or “our.”
- Met or surpassed fiscal year 2024 guidance ranges for all key financial metrics.
- Full year revenue of $732.7 million in 2024, an increase of 20.6% over the prior year, with the UTI division contributing $486.4 million and the Concorde division contributing $246.3 million.
- Full year net income was $42.0 million, an increase of 240.9% over the prior year.
- Full year adjusted EBITDA(1) was $102.9 million, an increase of 60.1% over the prior year.
- Full year total new student starts of 26,885, an increase of 18.9% over the prior year, with UTI contributing 15,138 and Concorde contributing 11,747.
- Established fiscal 2025 full year guidance ranges including revenue of $800–$815 million, net income of $52-56 million and adjusted EBITDA of $120–$124 million.
“We concluded the first stage of our North Star Strategy in fiscal 2024 achieving both strong results and momentum,” said Jerome Grant, CEO of Universal Technical Institute, Inc. “We met or exceeded guidance across all key metrics with full year revenue and adjusted EBITDA increasing over 21% and 60% year-over-year, respectively. These results reflect our consistent execution on the growth, diversification, and optimization tenets of our strategic plan as we continue ramping newly launched programs across both divisions, while further improving margins through workforce and facilities optimization.
“Building on the momentum generated this year, fiscal 2025 is on track to be another year of impressive growth as we enter Phase II of the North Star Strategy. We remain confident in achieving year-over-year revenue and adjusted EBITDA growth of at least 10% and 19%, respectively. We are beginning this next phase of our growth and diversification strategy with the Company positioned stronger than ever to drive long-term value for our shareholders.”
Financial Results for the Three-Month Period Ended September 30, 2024 Compared to 2023
- Revenues increased 15.3% to $196.4 million, compared to $170.3 million.
- Operating expenses increased 6.5% to $170.3 million, compared to $160.0 million.
- Operating income was $26.0 million compared to $10.3 million.
- Net income was $18.8 million compared to $6.7 million.
- Basic and diluted earnings per share (EPS) were $0.35 and $0.34, respectively, compared to $0.10.
- Adjusted EBITDA(1) increased 94.6% to $37.3 million, compared to $19.2 million.
- New student starts of 11,492 compared to 10,392.
UTI
- Revenues of $130.5 million, a 13.2% increase from the comparable period revenues of $115.3 million, due primarily to growth in average full-time active students.
- Operating expenses were $100.1 million, compared to $100.8 million. Expenses remained nearly flat despite expenses incurred during the current year for the new program launches.
- Adjusted EBITDA(1) increased 74.3% to $37.5 million compared to $21.5 million.
- New student starts increased 8.7% to 7,068, while average full-time active students increased 9.2%.
Concorde
- Revenues of $65.8 million, an increase of 19.7% over the comparable period revenues of $55.0 million, due primarily to growth in average full-time active students.
- Operating expenses were $59.1 million, compared to $51.8 million. The increase was primarily due to growth in average full-time active students and additional expenses incurred during the current year related to new program launches.
- Adjusted EBITDA(1) increased 108.0% to $8.3 million compared to $4.0 million.
- New student starts increased 13.7% to 4,424, while average full-time active students increased 13.8%.
Financial Results for the Year Ended September 30, 2024 Compared to 2023(2)
- Revenues increased 20.6% to $732.7 million, which exceeded our updated full-year guidance range of $720-730 million, compared to $607.4 million primarily due to growth in average full-time active students at both UTI and Concorde and the inclusion of two additional months of revenue for Concorde(2).
- Operating expenses increased 15.0% to $673.8 million, compared to $586.0 million, primarily due to the growth in average full-time active students at both UTI and Concorde, costs associated with program expansions and the inclusion of two additional months of expenses for Concorde(2).
- Operating income increased 175.2% to $58.9 million compared to $21.4 million.
- Net income was $42.0 million compared to $12.3 million.
- Basic and diluted EPS were $0.77 and $0.75, respectively, compared to $0.13.
- Adjusted EBITDA(1) increased 60.1% to $102.9 million, which was within the updated full year guidance range of $102-104 million, compared to $64.2 million.
- Net cash provided by operating activities increased 74.8% to $85.9 million compared to $49.1 million.
- Adjusted free cash flow(1) was $73.5 million, exceeding the full year guidance range of $62-66 million.
- New student starts of 26,885, exceeding our updated full year guidance range of 25,500-26,500.
UTI
- Revenues of $486.4 million, an increase of 13.3% over the prior year revenues of $429.3 million due to the growth in average full-time active students.
- Operating expenses were $408.6 million, compared to $386.6 million. The increase was primarily due to the growth in average full-time active students and expenses incurred during the current year for new program launches completed and currently underway.
- Adjusted EBITDA(1) increased 45.4% to $104.1 million compared to $71.6 million.
- New student starts increased 6.7% to 15,138, while average full-time active students increased 9.5%.
Concorde(2)
- Revenues of $246.3 million, an increase of 38.3% over the prior year revenues of $178.1 million due to the inclusion of two additional months of revenue during the current year, along with growth in average full-time active students.
- Operating expenses were $225.5 million compared to $167.6 million. The increase was due to the inclusion of two additional months of expenses during the current year and additional expenses related to higher average students and program launches.
- Adjusted EBITDA(1) increased 73.8% to $28.3 million compared to $16.3 million.
- New student starts increased 39.3% to 11,747, partially due to the inclusion of two additional months during the current year, while average full-time active students increased 10.7%.
Balance Sheet and Liquidity
At September 30, 2024, our total available liquidity was $230.9 million, including $69.0 million available from the revolving credit facility. Total debt at September 30, 2024 was $125.7 million, including $56.0 million drawn on the revolving credit facility. For fiscal 2024, the Company incurred $24.3 million of cash capital expenditures (“capex”) driven primarily by investments in program expansions for both UTI and Concorde, along with spending associated with curriculum and equipment refresh and upgrades, facility and leasehold improvements, and IT investments.
Fiscal 2025 Financial Outlook
“Our financial performance in fiscal 2024 underscores UTI’s disciplined approach to growth and operational efficiency as we have met or exceeded guidance across all core metrics for both the quarter and full year,” said Christine Kline, Interim CFO of Universal Technical Institute, Inc. “The Concorde division continued to surpass expectations driven by program expansions and newer programs maturing, as well as increased marketing and admissions spend, all of which boosted student growth. The UTI division delivered year-over-year growth in average full-time active students supported by continued growth across the programs launched in the current and prior year.
“Entering fiscal 2025, we are pleased to announce our formal guidance ranges for the fiscal year. With Phase II of our North Star strategy now underway, we’re well positioned to deliver continued sustainable growth through campus and program expansion initiatives, increased workforce and resource optimizations, and enhanced marketing and admissions yield. Furthermore, our balance sheet remains strong, allowing us to actively evaluate all growth opportunities.”
FY 2024 |
FY 2025 |
Year-Over-Year |
|||
($ in millions excluding new student starts and EPS) |
Actuals |
Guidance |
Growth(3) |
||
New student starts |
26,885 |
28,000 – 29,000 |
6 % |
||
Revenue |
$732.7 |
$800 – 815 |
10 % |
||
Net Income |
$42.0 |
$52 – 56 |
29 % |
||
Diluted EPS |
$0.75 |
$0.93 – 1.01 |
29 % |
||
Adjusted EBITDA(1)(4) |
$102.9 |
$120 – 124 |
19 % |
||
Adjusted free cash flow(1)(4)(5) |
$73.5 |
$58 – 62 |
(18) % |
(1) |
See the “Use of Non-GAAP Financial Information” below. For a detailed reconciliation of the non-GAAP measures, see the tables following the earnings release. |
(2) |
Fiscal 2023 reflects UTI results for the full year and Concorde results beginning December 1, 2022. Total company year-over-year comparisons are shown on an “as-reported basis.” |
(3) |
Year-over-year growth percentages are calculated using the fiscal 2025 guidance midpoint. |
(4) |
Beginning in FY2025, growth investments for program expansion and new campus initiatives will no longer be included as add-backs in Adjusted EBITDA and Adjusted free cash flow calculations, affecting the year-over-year comparability. |
(5) |
Includes $24.3 million of total capex for FY2024 primarily related to program expansions and a consistent level of annual maintenance capex. For FY 2025, assumes approximately $55M of total capex, including investments for new campus launches and program expansions, and maintenance capex. |
For the Company’s most recent investor presentation and quarterly financial supplement, please see its investor relations website at https://investor.uti.edu.
Conference Call
Management will hold a conference call to discuss the financial results for the fiscal 2024 fourth quarter and full year ended September 30, 2024, on Wednesday, November 20, 2024 at 4:30 pm EST.
To participate in the live call, investors are invited to dial (844) 881-0138 (domestic) or (412) 317-6790 (international). A live webcast of the call will be available via the Universal Technical Institute investor relations website at https://investor.uti.edu. Please go to the website at least 10 minutes early to register, download and install any necessary audio software. The conference call webcast will be archived for fourteen days at https://investor.uti.edu or the telephone replay can be accessed through December 4, 2024, by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering passcode 8876412.
Use of Non-GAAP Financial Information
In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles (“GAAP”), the Company also discloses certain non-GAAP financial information in this press release and may similarly disclose non-GAAP financial information on the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, the Company believes that these measures may also help investors compare its performance on a consistent basis across time periods. Additional details on our non-GAAP measures and the tables reconciling these measures to the most directly comparable GAAP measure are provided below.
Adjusted EBITDA
The Company defines adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation and amortization, adjusted for stock-based compensation expense and items not considered normal recurring operations.
Adjusted Free Cash Flow
The Company defines adjusted free cash flow as net cash provided by (used in) operating activities less capital expenditures, adjusted for items not considered normal recurring operations.
Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting. For the periods presented, our adjustments for items that management does not consider to be normal recurring operations include:
- Acquisition-related costs: We have excluded costs associated with both potential and announced acquisitions to allow for comparable financial results to historical operations and forward-looking guidance.
- Integration-related costs for completed acquisitions: We have excluded integration costs related to business structure realignment and new programs for recent acquisitions to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
- One-time costs associated with new campus openings: During fiscal 2022, we opened new campus locations in Austin, Texas and Miramar, Florida. We continued to incur one-time costs during fiscal 2023 for the campus opening as we completed the build-out of the remaining programs in the new facilities. We disclose any campus adjustments as direct costs (net of any corporate allocations). Outfitting a new campus requires significant facility improvements and modifications, and the purchase of technical equipment and training aids necessary for teaching our programs, the combination of which requires a significant investment by the Company which would not be considered part of normal recurring operations.
- Restructuring charges: In December 2023, we announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, began a phased teach-out in May 2024, and such campus began operating under the UTI brand. MIAT-Houston students who have not completed their programs before their program’s teach-out date may enroll at UTI-Houston to complete their program. Both facilities will remain in use post-consolidation.
- Facility lease accounting adjustments: During 2022, as part of our facility optimization project, we recorded lease accounting adjustments for lease termination payments associated with our Orlando, Florida and MMI Phoenix, Arizona campuses and a non-cash lease adjustment when we purchased our Lisle, Illinois campus. During 2024, we recorded a lease accounting adjustment for a lease termination payment for the previous Concorde corporate offices. These adjustments are not considered part of normal recurring operations.
- Costs related to the purchase of our campuses: We lease the majority of our campus locations. Over the past three years due to shifts within the real estate environment, we have been presented with the opportunity to purchase three of our campus locations. These purchases are significant capital expenditures and not considered part of normal recurring operations.
To obtain a complete understanding of our performance, these measures should be examined in connection with net income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission (“SEC”). Because the items excluded from these non-GAAP measures are significant components in understanding and assessing our financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss) or net cash provided by (used in) operating activities as a measure of our operating performance or liquidity. Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below and investors are encouraged to review the reconciliations.
Forward Looking Statements
All statements contained in this press release and the related conference call, other than statements of historical fact, are “forward-looking” statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements which address our expected future business and financial performance, may contain words such as “goal,” “target,” “future,” “estimate,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “project,” “may,” “should,” “will,” the negative form of these expressions or similar expressions. Examples of forward-looking statements include, among others, statements regarding (1) the Company’s expectation that it will meet its fiscal year 2025 guidance for new student start growth, revenue growth, net income, diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash Flow; (2) the Company’s expectation that it will continue to expand its value proposition and build a business that can grow in double digits with potential upside, regardless of the economic environment; and (3) the Company’s expectation that it will succeed in new program launches next year. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could affect our actual results include, among other things, failure of our schools to comply with the extensive regulatory requirements for school operations; our failure to maintain eligibility for or our ability to process federal student financial assistance funds; the effect of current and future Title IV Program regulations arising out of negotiated rulemakings, including any potential reductions in funding or restrictions on the use of funds received through Title IV Programs; the effect of future legislative or regulatory initiatives related to veterans’ benefit programs; continued Congressional examination of the for-profit education sector; regulatory investigations of, or actions commenced against, us or other companies in our industry; changes in the state regulatory environment or budgetary constraints; our failure to execute on our growth and diversification strategy, including effectively identifying, establishing and operating additional schools, programs or campuses; our failure to realize the expected benefits of our acquisitions, or our failure to successfully integrate our acquisitions.; our failure to improve underutilized capacity at certain of our campuses; enrollment declines or challenges in our students’ ability to find employment as a result of macroeconomic conditions; our failure to maintain and expand existing industry relationships and develop new industry relationships; our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes; a loss of our senior management or other key employees; failure to comply with the restrictive covenants and our ability to pay the amounts when due under the credit agreement; the effect of our principal stockholder owning a significant percentage of our capital stock, and thus being able to influence certain corporate matters and the potential in the future to gain substantial control over our company; the effect of public health pandemics, epidemics or outbreak, including COVID-19, and other risks that are described from time to time in our public filings. Further information on these and other potential factors that could affect the financial results or condition may be found in the company’s filings with the SEC. Any forward-looking statements made by us in this press release and the related conference call are based only on information currently available to us and speak only as of the date on which it is made. We expressly disclaim any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, changes in expectations, any changes in events, conditions or circumstances, or otherwise.
Social Media Disclosure
Universal Technical Institute (UTI) uses its websites (https://www.uti.edu/ and https://investor.uti.edu/) and LinkedIn page (https://www.linkedin.com/school/universal-technical-institute/) as channels of distribution of information about its programs, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and UTI may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor the company’s website and its social media accounts in addition to following the company’s press releases, SEC filings, public conference calls, and webcasts.
About Universal Technical Institute, Inc.
Universal Technical Institute, Inc. UTI was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. The Company is comprised of two divisions: Universal Technical Institute (“UTI”) and Concorde Career Colleges (“Concorde”). UTI operates 16 campuses located in nine states and offers a wide range of transportation and skilled trades technical training programs under brands such as UTI, MIAT College of Technology, Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute. Concorde operates across 17 campuses in eight states, offering programs in the Allied Health, Dental, Nursing, Patient Care and Diagnostic fields. For more information, visit www.uti.edu or www.concorde.edu, or visit us on LinkedIn at @UniversalTechnicalInstitute and @Concorde Career Colleges or on Twitter @news_UTI or @ConcordeCareer.
Company Contact:
Christine Kline
Interim Chief Financial Officer and Chief Accounting Officer
Universal Technical Institute, Inc.
(623) 445-9464
Media Contact:
Susan Aspey
Vice President, Corporate Affairs & External Communications
Universal Technical Institute, Inc.
(202) 549-0534
saspey@uti.edu
Investor Relations Contact:
Matt Glover or Cody Cree
Gateway Group, Inc.
(949) 574-3860
UTI@gateway-grp.com
(Tables Follow)
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
(In thousands, except per share amounts) |
|||||||
(Unaudited) |
|||||||
Three Months Ended |
Twelve Months Ended |
||||||
September 30, |
September 30, |
||||||
2024 |
2023 |
2024 |
2023 |
||||
Revenues |
$ 196,358 |
$ 170,298 |
$ 732,687 |
$ 607,408 |
|||
Operating expenses: |
|||||||
Educational services and facilities |
99,355 |
93,155 |
384,529 |
329,870 |
|||
Selling, general and administrative |
70,981 |
66,804 |
289,267 |
256,139 |
|||
Total operating expenses |
170,336 |
159,959 |
673,796 |
586,009 |
|||
Income from operations |
26,022 |
10,339 |
58,891 |
21,399 |
|||
Other (expense) income: |
|||||||
Interest income |
1,472 |
1,601 |
6,314 |
5,861 |
|||
Interest expense |
(2,267) |
(2,639) |
(9,471) |
(9,656) |
|||
Other income (expense) |
143 |
(57) |
496 |
483 |
|||
Total other (expense) income, net |
(652) |
(1,095) |
(2,661) |
(3,312) |
|||
Income before income taxes |
25,370 |
9,244 |
56,230 |
18,087 |
|||
Income tax expense |
(6,530) |
(2,541) |
(14,229) |
(5,765) |
|||
Net income |
18,840 |
6,703 |
42,001 |
12,322 |
|||
Preferred stock dividends |
— |
(1,278) |
(1,097) |
(5,069) |
|||
Income available for distribution |
18,840 |
5,425 |
40,904 |
7,253 |
|||
Income allocated to participating securities |
— |
(2,025) |
(2,855) |
(2,712) |
|||
Net income available to common shareholders |
$ 18,840 |
$ 3,400 |
$ 38,049 |
$ 4,541 |
|||
Earnings per share: |
|||||||
Net income per share – basic |
$ 0.35 |
$ 0.10 |
$ 0.77 |
$ 0.13 |
|||
Net income per share – diluted |
$ 0.34 |
$ 0.10 |
$ 0.75 |
$ 0.13 |
|||
Weighted average number of shares outstanding(1): |
|||||||
Basic |
53,813 |
34,070 |
49,429 |
33,985 |
|||
Diluted |
55,404 |
34,824 |
50,851 |
34,479 |
(1) |
On December 18, 2023, the Company exercised in full its right of conversion of the Company’s Series A Preferred Stock which resulted in the conversion of all outstanding Series A Preferred shares into 19,296,843 shares of Common Stock. As of September 30, 2024 there were 53,816,995 shares of Common Stock outstanding. |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(In thousands, except par value and per share amounts) |
|||
(Unaudited) |
|||
September 30, |
September 30, |
||
Assets |
|||
Cash and cash equivalents |
$ 161,900 |
$ 151,547 |
|
Restricted cash |
5,572 |
5,377 |
|
Receivables, net |
31,096 |
25,161 |
|
Notes receivable, current portion |
6,200 |
5,991 |
|
Prepaid expenses |
11,945 |
9,412 |
|
Other current assets |
5,238 |
7,497 |
|
Total current assets |
221,951 |
204,985 |
|
Property and equipment, net |
264,797 |
266,346 |
|
Goodwill |
28,459 |
28,459 |
|
Intangible assets, net |
18,229 |
18,975 |
|
Notes receivable, less current portion |
36,267 |
30,672 |
|
Right-of-use assets for operating leases |
158,778 |
176,657 |
|
Deferred tax assets |
3,563 |
3,768 |
|
Other assets |
12,531 |
10,823 |
|
Total assets |
$ 744,575 |
$ 740,685 |
|
Liabilities and Shareholders’ Equity |
|||
Accounts payable and accrued expenses |
$ 83,866 |
$ 69,941 |
|
Deferred revenue |
92,538 |
85,738 |
|
Operating lease liability, current portion |
22,210 |
22,481 |
|
Long-term debt, current portion |
2,697 |
2,517 |
|
Other current liabilities |
3,652 |
4,023 |
|
Total current liabilities |
204,963 |
184,700 |
|
Deferred tax liabilities |
4,696 |
663 |
|
Operating lease liability |
146,831 |
165,026 |
|
Long-term debt |
123,007 |
159,600 |
|
Other liabilities |
4,847 |
4,729 |
|
Total liabilities |
484,344 |
514,718 |
|
Commitments and contingencies |
|||
Shareholders’ equity: |
|||
Common stock, $0.0001 par value, 100,000 shares authorized, 53,899 and 34,157 shares issued, and 53,817 and 34,075 shares outstanding as of September 30, 2024 and 2023, respectively |
5 |
3 |
|
Preferred stock, $0.0001 par value, 10,000 shares authorized; 0 and 676 shares of Series A Convertible Preferred Stock issued and outstanding, liquidation preference of $100 per share as of September 30, 2024 and 2023, respectively |
— |
— |
|
Paid-in capital – common |
220,976 |
151,439 |
|
Paid-in capital – preferred |
— |
66,481 |
|
Treasury stock, at cost, 82 shares as of September 30, 2024 and 2023 |
(365) |
(365) |
|
Retained earnings |
38,509 |
5,946 |
|
Accumulated other comprehensive income |
1,106 |
2,463 |
|
Total shareholders’ equity |
260,231 |
225,967 |
|
Total liabilities and shareholders’ equity |
$ 744,575 |
$ 740,685 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||
(In thousands) (Unaudited) |
||||
Year Ended September 30, |
||||
2024 |
2023 |
|||
Cash flows from operating activities: |
||||
Net income |
$ 42,001 |
$ 12,322 |
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation and amortization |
29,324 |
25,215 |
||
Amortization of right-of-use assets for operating leases |
21,861 |
20,604 |
||
Provision for credit losses |
7,547 |
3,319 |
||
Stock-based compensation |
8,560 |
3,848 |
||
Deferred income taxes |
4,439 |
4,636 |
||
Unrealized (loss) gain on interest rate swaps, net of taxes |
(1,357) |
250 |
||
Other, net |
1,802 |
1,651 |
||
Changes in assets and liabilities: |
||||
Accounts and notes receivables |
(17,796) |
(5,726) |
||
Prepaid expenses and other current assets |
(3,651) |
(2,013) |
||
Accounts payable, accrued expenses and other current liabilities |
10,998 |
(5,885) |
||
Deferred revenue |
6,800 |
11,370 |
||
Operating lease liability |
(22,449) |
(20,474) |
||
All other assets and liabilities |
(2,184) |
31 |
||
Net cash provided by operating activities |
85,895 |
49,148 |
||
Cash flows from investing activities: |
||||
Purchase of property and equipment |
(24,298) |
(56,685) |
||
Proceeds received upon maturity of investments |
— |
29,000 |
||
Cash paid for acquisitions, net of cash acquired |
— |
(16,381) |
||
Other investing activities |
296 |
— |
||
Net cash used in investing activities |
(24,002) |
(44,066) |
||
Cash flows from financing activities: |
||||
Proceeds from revolving credit facility |
41,000 |
89,484 |
||
Payments on revolving credit facility |
(75,000) |
— |
||
Payment of term loans and finance leases |
(2,518) |
(1,788) |
||
Preferred share repurchase |
(11,503) |
— |
||
Payment of preferred stock cash dividend |
(1,097) |
(5,069) |
||
Payment of payroll taxes on stock-based compensation through shares withheld |
(2,227) |
(781) |
||
Net cash (used in) provided by financing activities |
(51,345) |
81,846 |
||
Change in cash, cash equivalents and restricted cash |
$ 10,548 |
$ 86,928 |
||
Cash and cash equivalents, beginning of period |
$ 151,547 |
$ 66,452 |
||
Restricted cash, beginning of period |
5,377 |
3,544 |
||
Cash, cash equivalents and restricted cash, beginning of period |
$ 156,924 |
$ 69,996 |
||
Cash and cash equivalents, end of period |
$ 161,900 |
$ 151,547 |
||
Restricted cash, end of period |
5,572 |
5,377 |
||
Cash, cash equivalents and restricted cash, end of period |
$ 167,472 |
$ 156,924 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
||||||||||||
SELECTED SUPPLEMENTAL NON-FINANCIAL AND FINANCIAL INFORMATION BY SEGMENT |
||||||||||||
(In thousands, except for Student Metrics) |
||||||||||||
(Unaudited) |
||||||||||||
Student Metrics |
||||||||||||
Three Months Ended September 30, 2024 |
Three Months Ended September 30, 2023 |
|||||||||||
UTI |
Concorde |
Total |
UTI |
Concorde |
Total |
|||||||
Total new student starts |
7,068 |
4,424 |
11,492 |
6,500 |
3,892 |
10,392 |
||||||
Year-over-year growth (decline) |
8.7 % |
13.7 % |
10.6 % |
9.0 % |
74.2 % |
|||||||
Average full-time active students |
14,067 |
9,113 |
23,180 |
12,883 |
8,008 |
20,891 |
||||||
Year-over-year growth (decline) |
9.2 % |
13.8 % |
11.0 % |
1.4 % |
64.4 % |
|||||||
End of period full-time active students |
15,873 |
9,747 |
25,620 |
14,833 |
8,369 |
23,202 |
||||||
Year-over-year growth (decline) |
7.0 % |
16.5 % |
10.4 % |
3.2 % |
61.3 % |
|||||||
Year Ended September 30, 2024 |
Year Ended September 30, 2023 |
|||||||||||
UTI |
Concorde |
Total |
UTI |
Concorde |
Total |
|||||||
Total new student starts |
15,138 |
11,747 |
26,885 |
14,181 |
8,432 |
22,613 |
||||||
Year-over-year growth (decline) |
6.7 % |
39.3 % |
18.9 % |
6.0 % |
69.1 % |
|||||||
Average full-time active students |
13,810 |
8,475 |
22,285 |
12,614 |
7,654 |
20,268 |
||||||
Year-over-year growth (decline) |
9.5 % |
10.7 % |
10.0 % |
(1.7) % |
57.9 % |
|||||||
End of period full-time active students |
15,873 |
9,747 |
25,620 |
14,833 |
8,369 |
23,202 |
||||||
Year-over-year growth (decline) |
7.0 % |
16.5 % |
10.4 % |
3.2 % |
61.3 % |
Financial Summary by Segment and Consolidated
During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the organizational structure that would best help the Company achieve future growth goals and optimally support the business. Beginning in fiscal 2024, we have executed an internal reorganization to fully transition our operating and reporting model to support a multi-divisional business. As part of the internal reorganization, each of the reportable segments now have dedicated accounting, finance, information technology, and human resources teams. Additionally, human resources and information technology costs that benefit the entire organization are now allocated across UTI, Concorde and Corporate each period based upon relative headcount. As a result, additional costs have moved from Corporate into the UTI segment and to a lesser extent the Concorde segment as resources were redirected to support the segment’s objectives. Due to these changes in allocation methodology, the prior year segment amounts have been recast for comparability to the current year presentation.
Three Months Ended September 30, 2024 |
Three Months Ended September 30, 2023 |
||||||||||||||||
UTI |
Concorde |
Corporate |
Consolidated |
UTI |
Concorde |
Corporate |
Consolidated |
||||||||||
Revenue |
$ 130,545 |
$ 65,813 |
$ — |
$ 196,358 |
$ 115,332 |
$ 54,966 |
$ — |
$ 170,298 |
|||||||||
Total operating expenses |
100,101 |
59,099 |
11,136 |
170,336 |
100,843 |
51,837 |
7,279 |
159,959 |
|||||||||
Net income (loss) |
28,760 |
6,777 |
(16,697) |
18,840 |
13,048 |
3,169 |
(9,514) |
6,703 |
|||||||||
Twelve Months Ended September 30, 2024 |
Twelve Months Ended September 30, 2023 |
||||||||||||||||
UTI |
Concorde |
Corporate |
Consolidated |
UTI |
Concorde |
Corporate |
Consolidated |
||||||||||
Revenue |
$ 486,376 |
$ 246,311 |
$ — |
$ 732,687 |
$ 429,317 |
$ 178,091 |
$ — |
$ 607,408 |
|||||||||
Total operating expenses |
408,620 |
225,507 |
39,669 |
673,796 |
386,555 |
167,558 |
31,896 |
586,009 |
|||||||||
Net income (loss) |
71,646 |
21,048 |
(50,693) |
42,001 |
38,324 |
10,700 |
(36,702) |
12,322 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||||||
SELECTED SUPPLEMENTAL NON-FINANCIAL AND FINANCIAL INFORMATION BY SEGMENT |
|||||||
(In thousands, except for Student Metrics) |
|||||||
(Unaudited) |
|||||||
Major Expense Categories by Segment and Consolidated |
|||||||
Three Months Ended September 30, 2024 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Salaries, benefits and tax expense |
$ 51,261 |
$ 31,799 |
$ 4,387 |
$ 87,447 |
|||
Bonus expense |
771 |
721 |
360 |
1,852 |
|||
Stock-based compensation |
778 |
81 |
2,003 |
2,862 |
|||
Total compensation and related costs |
$ 52,810 |
$ 32,601 |
$ 6,750 |
$ 92,161 |
|||
Advertising and marketing expense |
$ 11,518 |
$ 6,545 |
$ 180 |
$ 18,243 |
|||
Occupancy expense, net of subleases |
8,040 |
4,855 |
165 |
13,060 |
|||
Depreciation and amortization |
5,996 |
1,419 |
347 |
7,762 |
|||
Professional and contract services expense |
2,605 |
2,704 |
3,286 |
8,595 |
|||
Three Months Ended September 30, 2023 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Salaries, benefits and tax expense |
$ 45,751 |
$ 27,507 |
$ 2,786 |
$ 76,044 |
|||
Bonus expense |
4,430 |
742 |
2,333 |
7,505 |
|||
Stock-based compensation |
(107) |
— |
140 |
33 |
|||
Total compensation and related costs |
$ 50,074 |
$ 28,249 |
$ 5,259 |
$ 83,582 |
|||
Advertising and marketing expense |
$ 11,935 |
$ 5,786 |
$ — |
$ 17,721 |
|||
Occupancy expense, net of subleases |
8,090 |
5,982 |
157 |
14,229 |
|||
Depreciation and amortization |
6,124 |
439 |
3 |
6,566 |
|||
Professional and contract services expense |
2,922 |
1,509 |
2,030 |
6,461 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||||||
SELECTED SUPPLEMENTAL NON-FINANCIAL AND FINANCIAL INFORMATION BY SEGMENT |
|||||||
(In thousands, except for Student Metrics) |
|||||||
(Unaudited) |
|||||||
Major Expense Categories by Segment and Consolidated |
|||||||
Twelve Months Ended September 30, 2024 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Salaries, benefits and tax expense |
$ 197,538 |
$ 121,359 |
$ 15,857 |
$ 334,754 |
|||
Bonus expense |
11,803 |
3,507 |
4,977 |
20,287 |
|||
Stock-based compensation |
2,080 |
213 |
6,267 |
8,560 |
|||
Total compensation and related costs |
$ 211,421 |
$ 125,079 |
$ 27,101 |
$ 363,601 |
|||
Advertising and marketing expense |
$ 51,940 |
$ 25,744 |
$ 577 |
$ 78,261 |
|||
Occupancy expense, net of subleases |
31,068 |
22,012 |
693 |
53,773 |
|||
Depreciation and amortization |
22,917 |
5,158 |
1,249 |
29,324 |
|||
Professional and contract services expense |
10,421 |
9,683 |
11,861 |
31,965 |
|||
Twelve Months Ended September 30, 2023 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Salaries, benefits and tax expense |
$ 183,607 |
$ 89,639 |
$ 13,777 |
$ 287,023 |
|||
Bonus expense |
13,284 |
2,594 |
5,141 |
21,019 |
|||
Stock-based compensation |
1,069 |
— |
2,779 |
3,848 |
|||
Total compensation and related costs |
$ 197,960 |
$ 92,233 |
$ 21,697 |
$ 311,890 |
|||
Advertising and marketing expense |
$ 52,809 |
$ 19,358 |
$ — |
$ 72,167 |
|||
Occupancy expense, net of subleases |
31,442 |
19,626 |
593 |
51,661 |
|||
Depreciation and amortization |
21,113 |
4,077 |
25 |
25,215 |
|||
Professional and contract services expense |
11,856 |
4,968 |
9,110 |
25,934 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||||||
RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
Reconciliation of Net Income to EBITDA and Adjusted EBITDA |
|||||||
Three Months Ended September 30, 2024 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Net income (loss) |
$ 28,760 |
$ 6,777 |
$ (16,697) |
$ 18,840 |
|||
Interest expense (income), net |
1,689 |
(63) |
(831) |
795 |
|||
Income tax expense |
— |
— |
6,530 |
6,530 |
|||
Depreciation and amortization |
5,996 |
1,419 |
347 |
7,762 |
|||
EBITDA |
36,445 |
8,133 |
(10,651) |
33,927 |
|||
Integration-related costs for completed acquisitions (1) |
187 |
730 |
209 |
1,126 |
|||
Stock-based compensation expense |
778 |
81 |
2,003 |
2,862 |
|||
Restructuring costs |
44 |
— |
— |
44 |
|||
Facility lease accounting adjustments |
— |
(650) |
— |
(650) |
|||
Adjusted EBITDA, non-GAAP |
$ 37,454 |
$ 8,294 |
$ (8,439) |
$ 37,309 |
|||
Three Months Ended September 30, 2023 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Net income (loss) |
$ 13,048 |
$ 3,169 |
$ (9,514) |
$ 6,703 |
|||
Interest expense (income), net |
1,468 |
(40) |
(390) |
1,038 |
|||
Income tax expense |
— |
— |
2,541 |
2,541 |
|||
Depreciation and amortization |
6,124 |
439 |
3 |
6,566 |
|||
EBITDA |
20,640 |
3,568 |
(7,360) |
16,848 |
|||
Acquisition related costs |
— |
— |
56 |
56 |
|||
Integration-related costs for completed acquisitions (1) |
923 |
419 |
858 |
2,200 |
|||
Stock-based compensation expense |
(107) |
— |
140 |
33 |
|||
One-time costs associated with new campus openings |
32 |
— |
— |
32 |
|||
Adjusted EBITDA, non-GAAP |
$ 21,488 |
$ 3,987 |
$ (6,306) |
$ 19,169 |
(1) |
Costs related to integrating the MIAT programs at the UTI campuses and launching Concorde programs that were previously approved by regulatory bodies prior to the acquisition are presented in “Integration-related costs for completed acquisitions.” In prior quarters, these costs were presented in a line labeled “Start-up costs for new campuses and program expansion.” As the nature of the spend and activity are more aligned to integration, we have updated our presentation and recast the prior year for comparability. |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|||||||
RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
Reconciliation of Net Income to EBITDA and Adjusted EBITDA |
|||||||
Twelve Months Ended September 30, 2024 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Net income (loss) |
$ 71,646 |
$ 21,048 |
$ (50,693) |
$ 42,001 |
|||
Interest expense (income), net |
6,135 |
(244) |
(2,734) |
3,157 |
|||
Income tax expense |
— |
— |
14,229 |
14,229 |
|||
Depreciation and amortization |
22,917 |
5,158 |
1,249 |
29,324 |
|||
EBITDA |
100,698 |
25,962 |
(37,949) |
88,711 |
|||
Integration-related costs for completed acquisitions (1) |
1,150 |
2,802 |
2,097 |
6,049 |
|||
Stock-based compensation expense |
2,080 |
213 |
6,267 |
8,560 |
|||
Restructuring Costs |
185 |
— |
— |
185 |
|||
Facility lease accounting adjustments |
— |
(650) |
— |
(650) |
|||
Adjusted EBITDA, non-GAAP |
$ 104,113 |
$ 28,327 |
$ (29,585) |
$ 102,855 |
|||
Twelve Months Ended September 30, 2023 |
|||||||
UTI |
Concorde |
Corporate |
Consolidated |
||||
Net income (loss) |
$ 38,324 |
$ 10,700 |
$ (36,702) |
$ 12,322 |
|||
Interest expense (income), net |
4,682 |
(167) |
(720) |
3,795 |
|||
Income tax benefit |
— |
— |
5,765 |
5,765 |
|||
Depreciation and amortization |
21,113 |
4,077 |
25 |
25,215 |
|||
EBITDA |
64,119 |
14,610 |
(31,632) |
47,097 |
|||
Acquisition related costs |
— |
— |
2,374 |
2,374 |
|||
Integration-related costs for completed acquisitions (1) |
4,061 |
1,686 |
2,838 |
8,585 |
|||
Stock-based compensation expense |
1,069 |
— |
2,779 |
3,848 |
|||
One-time costs associated with new campus openings |
2,341 |
— |
— |
2,341 |
|||
Adjusted EBITDA, non-GAAP |
$ 71,590 |
$ 16,296 |
$ (23,641) |
$ 64,245 |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
||||
RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION |
||||
(In thousands) |
||||
(Unaudited) |
||||
Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow |
||||
Twelve Months Ended September 30, |
||||
2024 |
2023 |
|||
Net cash provided by operating activities, as reported |
$ 85,895 |
$ 49,148 |
||
Purchase of property and equipment |
(24,298) |
(56,685) |
||
Free cash flow, non-GAAP |
61,597 |
(7,537) |
||
Adjustments: |
||||
Cash outflow to purchase of Orlando, FL campus buildings |
— |
26,156 |
||
Cash outflow for acquisition-related costs |
— |
2,347 |
||
Cash outflow for integration-related costs for completed acquisitions(2) |
6,196 |
7,768 |
||
Cash outflow for integration-related property and equipment(2) |
4,330 |
10,530 |
||
Cash outflow for restructuring costs and property and equipment |
632 |
— |
||
Cash outflow for one-time costs associated with new campus openings |
— |
2,341 |
||
Cash outflow for property and equipment associated with new campus openings |
— |
7,484 |
||
Facility lease accounting adjustments |
700 |
— |
||
Adjusted free cash flow, non-GAAP |
$ 73,455 |
$ 49,089 |
(2) |
Costs related to integrating the MIAT programs at the UTI campuses and launching Concorde programs that were previously approved by regulatory bodies prior to the acquisition are presented in “Cash outflow for integration-related costs for completed acquisitions” and “Cash outflow for integration-related property and equipment.” In prior quarters, these costs were presented in the lines labeled “”Cash outflow for start-up costs for new campuses and programs expansion” and “Cash outflow for property and equipment for new campuses and program expansion.” As the nature of the spend and activity are more aligned to integration, we have updated our presentation and recast the prior year for comparability. |
UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES |
|
RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL |
|
INFORMATION FOR FISCAL 2024 GUIDANCE |
|
(In thousands) |
|
(Unaudited) |
For each of the non-GAAP reconciliations provided for fiscal 2025 guidance, we are reconciling to the midpoint of the guidance range. The adjustments reflected below for fiscal 2025 are illustrative only and may change throughout the year, both in amount or the adjustments themselves.
Reconciliation of Net Income to EBITDA and Adjusted EBITDA for Fiscal 2025 Guidance |
|
Twelve Months Ended |
|
September 30, |
|
2025 |
|
Net income |
~ $54,000 |
Interest (income) expense, net |
~ 1,000 |
Income tax expense |
~ 20,000 |
Depreciation and amortization |
~ 33,000 |
EBITDA |
~ 108,000 |
Acquisition related costs(1) |
~ 3,000 |
Stock-based compensation expense |
~ 9,000 |
Restructuring costs |
~ 2,000 |
Adjusted EBITDA, non-GAAP |
~ $122,000 |
FY 2025 Guidance Range |
$120,000 – $124,000 |
Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow for Fiscal 2025 Guidance |
|
Twelve Months Ended |
|
September 30, |
|
2025 |
|
Net cash provided by operating activities |
~ $110,000 |
Purchase of property and equipment |
~ (55,000) |
Free cash flow, non-GAAP |
~ 55,000 |
Adjustments: |
|
Cash outflow for acquisition related costs(1) |
~ 3,000 |
Cash outflow for restructuring costs and property and equipment |
~ 2,000 |
Adjusted free cash flow, non-GAAP |
~ $60,000 |
FY 2025 Guidance Range |
$58,000 – $62,000 |
(1) |
FY25 projected spend on acquisition related costs is an estimate and is fully contingent on whether the Company pursues an acquisition this year. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/universal-technical-institute-reports-fiscal-year-2024-fourth-quarter-and-year-end-results-302311828.html
SOURCE Universal Technical Institute, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
NVIDIA Announces Financial Results for Third Quarter Fiscal 2025
- Record quarterly revenue of $35.1 billion, up 17% from Q2 and up 94% from a year ago
- Record quarterly Data Center revenue of $30.8 billion, up 17% from Q2 and up 112% from a year ago
SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) — NVIDIA NVDA today reported revenue for the third quarter ended October 27, 2024, of $35.1 billion, up 17% from the previous quarter and up 94% from a year ago.
For the quarter, GAAP earnings per diluted share was $0.78, up 16% from the previous quarter and up 111% from a year ago. Non-GAAP earnings per diluted share was $0.81, up 19% from the previous quarter and up 103% from a year ago.
“The age of AI is in full steam, propelling a global shift to NVIDIA computing,” said Jensen Huang, founder and CEO of NVIDIA. “Demand for Hopper and anticipation for Blackwell — in full production — are incredible as foundation model makers scale pretraining, post-training and inference.
“AI is transforming every industry, company and country. Enterprises are adopting agentic AI to revolutionize workflows. Industrial robotics investments are surging with breakthroughs in physical AI. And countries have awakened to the importance of developing their national AI and infrastructure,” he said.
NVIDIA will pay its next quarterly cash dividend of $0.01 per share on December 27, 2024, to all shareholders of record on December 5, 2024.
Q3 Fiscal 2025 Summary
GAAP | |||||||||||
($ in millions, except earnings per share) |
Q3 FY25 | Q2 FY25 | Q3 FY24 | Q/Q | Y/Y | ||||||
Revenue | $ | 35,082 | $ | 30,040 | $ | 18,120 | Up 17% | Up 94% | |||
Gross margin | 74.6 | % | 75.1 | % | 74.0 | % | Down 0.5 pts | Up 0.6 pts | |||
Operating expenses | $ | 4,287 | $ | 3,932 | $ | 2,983 | Up 9% | Up 44% | |||
Operating income | $ | 21,869 | $ | 18,642 | $ | 10,417 | Up 17% | Up 110% | |||
Net income | $ | 19,309 | $ | 16,599 | $ | 9,243 | Up 16% | Up 109% | |||
Diluted earnings per share* | $ | 0.78 | $ | 0.67 | $ | 0.37 | Up 16% | Up 111% |
Non-GAAP | |||||||||||
($ in millions, except earnings per share) |
Q3 FY25 | Q2 FY25 | Q3 FY24 | Q/Q | Y/Y | ||||||
Revenue | $ | 35,082 | $ | 30,040 | $ | 18,120 | Up 17% | Up 94% | |||
Gross margin | 75.0 | % | 75.7 | % | 75.0 | % | Down 0.7 pts | — | |||
Operating expenses | $ | 3,046 | $ | 2,792 | $ | 2,026 | Up 9% | Up 50% | |||
Operating income | $ | 23,276 | $ | 19,937 | $ | 11,557 | Up 17% | Up 101% | |||
Net income | $ | 20,010 | $ | 16,952 | $ | 10,020 | Up 18% | Up 100% | |||
Diluted earnings per share* | $ | 0.81 | $ | 0.68 | $ | 0.40 | Up 19% | Up 103% |
*All per share amounts presented herein have been retroactively adjusted to reflect the ten-for-one stock split, which was effective June 7, 2024.
Outlook
NVIDIA’s outlook for the fourth quarter of fiscal 2025 is as follows:
- Revenue is expected to be $37.5 billion, plus or minus 2%.
- GAAP and non-GAAP gross margins are expected to be 73.0% and 73.5%, respectively, plus or minus 50 basis points.
- GAAP and non-GAAP operating expenses are expected to be approximately $4.8 billion and $3.4 billion, respectively.
- GAAP and non-GAAP other income and expense are expected to be an income of approximately $400 million, excluding gains and losses from non-affiliated investments and publicly-held equity securities.
- GAAP and non-GAAP tax rates are expected to be 16.5%, plus or minus 1%, excluding any discrete items.
Highlights
NVIDIA achieved progress since its previous earnings announcement in these areas:
Data Center
- Third-quarter revenue was a record $30.8 billion, up 17% from the previous quarter and up 112% from a year ago.
- Announced the availability of NVIDIA Hopper H200-powered instances in several cloud services, including AWS, CoreWeave and Microsoft Azure, with Google Cloud and Oracle Cloud Infrastructure coming soon.
- Launched Denmark’s largest sovereign AI supercomputer, an NVIDIA® DGX SuperPOD™ driven by 1,528 NVIDIA H100 Tensor Core GPUs and interconnected using NVIDIA Quantum-2 InfiniBand networking.
- Introduced the NVIDIA AI Aerial platform for telecommunications providers and began working with T-Mobile, Ericsson and Nokia to accelerate the commercialization of AI-RAN.
- Announced that SoftBank Corp. is building Japan’s most powerful AI supercomputer with the NVIDIA Blackwell platform and has successfully piloted the world’s first combined AI and 5G telecom network using NVIDIA AI Aerial.
- Revealed that cloud leaders in India, Japan and Indonesia are building AI infrastructure with NVIDIA accelerated computing, while consulting leaders are helping speed AI adoption across industries with NVIDIA AI Enterprise software.
- Accelerated xAI’s Colossus supercomputer cluster, using 100,000 NVIDIA Hopper GPUs, with the NVIDIA Spectrum-X™ Ethernet networking platform.
- Unveiled a partnership with Foxconn to build Taiwan’s fastest AI supercomputer with NVIDIA Blackwell.
- Announced that Blackwell debuted on MLPerf Training, completed all tests and delivered up to 2.2x performance gains on large language model benchmarks.
- Contributed foundational elements of the NVIDIA Blackwell design to the Open Compute Project and broadened NVIDIA Spectrum-X support for OCP standards.
- Revealed that U.S. technology companies including Accenture, Deloitte and Google Cloud are tapping NVIDIA AI software to create custom AI applications, transforming industries worldwide.
- Announced the expansion of a partnership with Lenovo to launch new hybrid AI solutions and systems optimized to run NVIDIA AI Enterprise software.
Gaming and AI PC
- Third-quarter Gaming revenue was $3.3 billion, up 14% from the previous quarter and up 15% from a year ago.
- Celebrated the 25th anniversary of GeForce® 256, the world’s first GPU, which marked a breakthrough for gaming and laid the foundation for an AI-driven future.
- Demonstrated NVIDIA ACE and digital human technologies in Mecha BREAK, featuring the Minitron 4B model for better in-game character responses, at Gamescom.
- Introduced 20 GeForce RTX and DLSS titles, including Indiana Jones and the Great Circle and Dragon Age: The Veilguard.
- Began shipping new RTX AI PCs with 321 AI trillion operations per second of performance from ASUS and MSI, with Microsoft Copilot+ capabilities anticipated next quarter.
Professional Visualization
- Third-quarter revenue was $486 million, up 7% from the previous quarter and up 17% from a year ago.
- Announced that Foxconn is using digital twins and industrial AI built on NVIDIA Omniverse™ to bring online faster three factories used to manufacture NVIDIA GB200 Grace Blackwell Superchips.
- Revealed that leading industrial manufacturers in India, including Reliance and Ola Motors, and Japan, including Toyota, Yaskawa, and Seven and I Holdings, are using NVIDIA AI and Omniverse to automate workflows and drive more efficient operations.
- Unveiled NVIDIA Holoscan for Media, an AI-enabled, software-defined platform that allows live media and video pipelines to run on the same infrastructure as AI, enhancing production delivery.
Automotive and Robotics
- Third-quarter Automotive revenue was $449 million, up 30% from the previous quarter and up 72% from a year ago.
- Revealed that Volvo is releasing a new electric SUV built on NVIDIA accelerated computing.
- Introduced Project GR00T AI and simulation tools for robot learning and humanoid development, and new generative AI tools and perception workflows for robotics developers.
- Announced that Japanese and Indian companies including Toyota and Ola Motors are using NVIDIA Isaac™ and Omniverse to build the next wave of physical AI.
CFO Commentary
Commentary on the quarter by Colette Kress, NVIDIA’s executive vice president and chief financial officer, is available at https://investor.nvidia.com.
Conference Call and Webcast Information
NVIDIA will conduct a conference call with analysts and investors to discuss its third quarter fiscal 2025 financial results and current financial prospects today at 2 p.m. Pacific time (5 p.m. Eastern time). A live webcast (listen-only mode) of the conference call will be accessible at NVIDIA’s investor relations website, https://investor.nvidia.com. The webcast will be recorded and available for replay until NVIDIA’s conference call to discuss its financial results for its fourth quarter and fiscal 2025.
Non-GAAP Measures
To supplement NVIDIA’s condensed consolidated financial statements presented in accordance with GAAP, the company uses non-GAAP measures of certain components of financial performance. These non-GAAP measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP other income (expense), net, non-GAAP net income, non-GAAP net income, or earnings, per diluted share, and free cash flow. For NVIDIA’s investors to be better able to compare its current results with those of previous periods, the company has shown a reconciliation of GAAP to non-GAAP financial measures. These reconciliations adjust the related GAAP financial measures to exclude stock-based compensation expense, acquisition-related and other costs, other, gains and losses from non-affiliated investments and publicly-held equity securities, net, interest expense related to amortization of debt discount, and the associated tax impact of these items where applicable. Free cash flow is calculated as GAAP net cash provided by operating activities less both purchases related to property and equipment and intangible assets and principal payments on property and equipment and intangible assets. NVIDIA believes the presentation of its non-GAAP financial measures enhances the user’s overall understanding of the company’s historical financial performance. The presentation of the company’s non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the company’s financial results prepared in accordance with GAAP, and the company’s non-GAAP measures may be different from non-GAAP measures used by other companies.
NVIDIA CORPORATION | |||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||
(In millions, except per share data) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
October 27, | October 29, | October 27, | October 29, | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||
Revenue | $ | 35,082 | $ | 18,120 | $ | 91,166 | $ | 38,819 | |||||||||
Cost of revenue | 8,926 | 4,720 | 22,031 | 11,309 | |||||||||||||
Gross profit | 26,156 | 13,400 | 69,135 | 27,510 | |||||||||||||
Operating expenses | |||||||||||||||||
Research and development | 3,390 | 2,294 | 9,200 | 6,210 | |||||||||||||
Sales, general and administrative | 897 | 689 | 2,516 | 1,942 | |||||||||||||
Total operating expenses | 4,287 | 2,983 | 11,716 | 8,152 | |||||||||||||
Operating Income | 21,869 | 10,417 | 57,419 | 19,358 | |||||||||||||
Interest income | 472 | 234 | 1,275 | 572 | |||||||||||||
Interest expense | (61 | ) | (63 | ) | (186 | ) | (194 | ) | |||||||||
Other, net | 36 | (66 | ) | 301 | (24 | ) | |||||||||||
Other income (expense), net | 447 | 105 | 1,390 | 354 | |||||||||||||
Income before income tax | 22,316 | 10,522 | 58,809 | 19,712 | |||||||||||||
Income tax expense | 3,007 | 1,279 | 8,020 | 2,237 | |||||||||||||
Net income | $ | 19,309 | $ | 9,243 | $ | 50,789 | $ | 17,475 | |||||||||
Net income per share (A): | |||||||||||||||||
Basic | $ | 0.79 | $ | 0.37 | $ | 2.07 | $ | 0.71 | |||||||||
Diluted | $ | 0.78 | $ | 0.37 | $ | 2.04 | $ | 0.70 | |||||||||
Weighted average shares used in per share computation (A): | |||||||||||||||||
Basic | 24,533 | 24,680 | 24,577 | 24,700 | |||||||||||||
Diluted | 24,774 | 24,940 | 24,837 | 24,940 | |||||||||||||
(A) Reflects a ten-for-one stock split on June 7, 2024. | |||||||||||||||||
NVIDIA CORPORATION | |||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
(In millions) | |||||||||
(Unaudited) | |||||||||
October 27, | January 28, | ||||||||
2024 | 2024 | ||||||||
ASSETS | |||||||||
Current assets: | |||||||||
Cash, cash equivalents and marketable securities | $ | 38,487 | $ | 25,984 | |||||
Accounts receivable, net | 17,693 | 9,999 | |||||||
Inventories | 7,654 | 5,282 | |||||||
Prepaid expenses and other current assets | 3,806 | 3,080 | |||||||
Total current assets | 67,640 | 44,345 | |||||||
Property and equipment, net | 5,343 | 3,914 | |||||||
Operating lease assets | 1,755 | 1,346 | |||||||
Goodwill | 4,724 | 4,430 | |||||||
Intangible assets, net | 838 | 1,112 | |||||||
Deferred income tax assets | 10,276 | 6,081 | |||||||
Other assets | 5,437 | 4,500 | |||||||
Total assets | $ | 96,013 | $ | 65,728 | |||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||
Current liabilities: | |||||||||
Accounts payable | $ | 5,353 | $ | 2,699 | |||||
Accrued and other current liabilities | 11,126 | 6,682 | |||||||
Short-term debt | – | 1,250 | |||||||
Total current liabilities | 16,479 | 10,631 | |||||||
Long-term debt | 8,462 | 8,459 | |||||||
Long-term operating lease liabilities | 1,490 | 1,119 | |||||||
Other long-term liabilities | 3,683 | 2,541 | |||||||
Total liabilities | 30,114 | 22,750 | |||||||
Shareholders’ equity | 65,899 | 42,978 | |||||||
Total liabilities and shareholders’ equity | $ | 96,013 | $ | 65,728 | |||||
NVIDIA CORPORATION | ||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||||||
(In millions) | ||||||||||||||||||
(Unaudited) | ||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||
October 27, | October 29, | October 27, | October 29, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||
Net income | $ | 19,309 | $ | 9,243 | $ | 50,789 | $ | 17,475 | ||||||||||
Adjustments to reconcile net income to net cash | ||||||||||||||||||
provided by operating activities: | ||||||||||||||||||
Stock-based compensation expense | 1,252 | 979 | 3,416 | 2,555 | ||||||||||||||
Depreciation and amortization | 478 | 372 | 1,321 | 1,121 | ||||||||||||||
(Gains) losses on investments in non-affiliated entities and publicly-held equity securities, net | (37 | ) | 69 | (302 | ) | 24 | ||||||||||||
Deferred income taxes | (602 | ) | (529 | ) | (3,879 | ) | (2,411 | ) | ||||||||||
Other | (79 | ) | (66 | ) | (365 | ) | (170 | ) | ||||||||||
Changes in operating assets and liabilities, net of acquisitions: | ||||||||||||||||||
Accounts receivable | (3,561 | ) | (1,243 | ) | (7,694 | ) | (4,482 | ) | ||||||||||
Inventories | (978 | ) | (457 | ) | (2,357 | ) | 405 | |||||||||||
Prepaid expenses and other assets | (714 | ) | 254 | (726 | ) | (337 | ) | |||||||||||
Accounts payable | 1,689 | 461 | 2,490 | 1,250 | ||||||||||||||
Accrued and other current liabilities | 606 | (1,722 | ) | 3,918 | 953 | |||||||||||||
Other long-term liabilities | 266 | (28 | ) | 849 | 208 | |||||||||||||
Net cash provided by operating activities | 17,629 | 7,333 | 47,460 | 16,591 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||
Proceeds from maturities of marketable securities | 1,386 | 2,891 | 9,485 | 8,001 | ||||||||||||||
Proceeds from sales of marketable securities | 154 | – | 318 | – | ||||||||||||||
Purchases of marketable securities | (4,518 | ) | (5,345 | ) | (19,565 | ) | (10,688 | ) | ||||||||||
Purchase related to property and equipment and intangible assets | (813 | ) | (278 | ) | (2,159 | ) | (815 | ) | ||||||||||
Acquisitions, net of cash acquired | (147 | ) | – | (465 | ) | (83 | ) | |||||||||||
Purchases of investments in non-affiliated entities | (473 | ) | (441 | ) | (1,008 | ) | (897 | ) | ||||||||||
Proceeds from sales of investments in non-affiliated entities | 66 | – | 171 | – | ||||||||||||||
Other | – | 4 | – | 25 | ||||||||||||||
Net cash used in investing activities | (4,345 | ) | (3,169 | ) | (13,223 | ) | (4,457 | ) | ||||||||||
Cash flows from financing activities: | ||||||||||||||||||
Proceeds related to employee stock plans | 204 | 156 | 489 | 403 | ||||||||||||||
Payments related to repurchases of common stock | (10,998 | ) | (3,806 | ) | (25,895 | ) | (6,874 | ) | ||||||||||
Repayment of debt | – | – | (1,250 | ) | (1,250 | ) | ||||||||||||
Payments related to tax on restricted stock units | (1,680 | ) | (764 | ) | (5,068 | ) | (1,942 | ) | ||||||||||
Dividends paid | (245 | ) | (99 | ) | (589 | ) | (296 | ) | ||||||||||
Principal payments on property and equipment and intangible assets | (29 | ) | (13 | ) | (97 | ) | (44 | ) | ||||||||||
Other | – | (1 | ) | – | (1 | ) | ||||||||||||
Net cash used in financing activities | (12,748 | ) | (4,527 | ) | (32,410 | ) | (10,004 | ) | ||||||||||
Change in cash, cash equivalents, and restricted cash | 536 | (363 | ) | 1,827 | 2,130 | |||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 8,571 | 5,882 | 7,280 | 3,389 | ||||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 9,107 | $ | 5,519 | $ | 9,107 | $ | 5,519 | ||||||||||
Supplemental disclosures of cash flow information: | ||||||||||||||||||
Cash paid for income taxes, net | $ | 3,540 | $ | 4,348 | $ | 10,989 | $ | 4,676 | ||||||||||
NVIDIA CORPORATION | ||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES | ||||||||||||||||||||||
(In millions, except per share data) | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
October 27, | July 28, | October 29, | October 27, | October 29, | ||||||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||
GAAP gross profit | $ | 26,156 | $ | 22,574 | $ | 13,400 | $ | 69,135 | $ | 27,510 | ||||||||||||
GAAP gross margin | 74.6 | % | 75.1 | % | 74.0 | % | 75.8 | % | 70.9 | % | ||||||||||||
Acquisition-related and other costs (A) | 116 | 118 | 119 | 355 | 358 | |||||||||||||||||
Stock-based compensation expense (B) | 50 | 40 | 38 | 125 | 96 | |||||||||||||||||
Other (C) | – | (3 | ) | 26 | (4 | ) | 36 | |||||||||||||||
Non-GAAP gross profit | $ | 26,322 | $ | 22,729 | $ | 13,583 | $ | 69,611 | $ | 28,000 | ||||||||||||
Non-GAAP gross margin | 75.0 | % | 75.7 | % | 75.0 | % | 76.4 | % | 72.1 | % | ||||||||||||
GAAP operating expenses | $ | 4,287 | $ | 3,932 | $ | 2,983 | $ | 11,716 | $ | 8,152 | ||||||||||||
Stock-based compensation expense (B) | (1,202 | ) | (1,114 | ) | (941 | ) | (3,291 | ) | (2,459 | ) | ||||||||||||
Acquisition-related and other costs (A) | (39 | ) | (26 | ) | (16 | ) | (86 | ) | (88 | ) | ||||||||||||
Other (C) | – | – | – | – | 10 | |||||||||||||||||
Non-GAAP operating expenses | $ | 3,046 | $ | 2,792 | $ | 2,026 | $ | 8,339 | $ | 5,615 | ||||||||||||
GAAP operating income | $ | 21,869 | $ | 18,642 | $ | 10,417 | $ | 57,419 | $ | 19,358 | ||||||||||||
Total impact of non-GAAP adjustments to operating income | 1,407 | 1,295 | 1,140 | 3,853 | 3,027 | |||||||||||||||||
Non-GAAP operating income | $ | 23,276 | $ | 19,937 | $ | 11,557 | $ | 61,272 | $ | 22,385 | ||||||||||||
GAAP other income (expense), net | $ | 447 | $ | 572 | $ | 105 | $ | 1,390 | $ | 354 | ||||||||||||
(Gains) losses from non-affiliated investments and publicly-held equity securities, net | (37 | ) | (193 | ) | 69 | (302 | ) | 23 | ||||||||||||||
Interest expense related to amortization of debt discount | 1 | 1 | 1 | 3 | 3 | |||||||||||||||||
Non-GAAP other income (expense), net | $ | 411 | $ | 380 | $ | 175 | $ | 1,091 | $ | 380 | ||||||||||||
GAAP net income | $ | 19,309 | $ | 16,599 | $ | 9,243 | $ | 50,789 | $ | 17,475 | ||||||||||||
Total pre-tax impact of non-GAAP adjustments | 1,371 | 1,103 | 1,210 | 3,554 | 3,053 | |||||||||||||||||
Income tax impact of non-GAAP adjustments (D) | (670 | ) | (750 | ) | (433 | ) | (2,144 | ) | (1,055 | ) | ||||||||||||
Non-GAAP net income | $ | 20,010 | $ | 16,952 | $ | 10,020 | $ | 52,199 | $ | 19,473 | ||||||||||||
Diluted net income per share (E) | ||||||||||||||||||||||
GAAP | $ | 0.78 | $ | 0.67 | $ | 0.37 | $ | 2.04 | $ | 0.70 | ||||||||||||
Non-GAAP | $ | 0.81 | $ | 0.68 | $ | 0.40 | $ | 2.10 | $ | 0.78 | ||||||||||||
Weighted average shares used in diluted net income per share computation (E) | 24,774 | 24,848 | 24,940 | 24,837 | 24,940 | |||||||||||||||||
GAAP net cash provided by operating activities | $ | 17,629 | $ | 14,489 | $ | 7,333 | $ | 47,460 | $ | 16,591 | ||||||||||||
Purchases related to property and equipment and intangible assets | (813 | ) | (977 | ) | (278 | ) | (2,159 | ) | (815 | ) | ||||||||||||
Principal payments on property and equipment and intangible assets | (29 | ) | (29 | ) | (13 | ) | (97 | ) | (44 | ) | ||||||||||||
Free cash flow | $ | 16,787 | $ | 13,483 | $ | 7,042 | $ | 45,204 | $ | 15,732 | ||||||||||||
(A) Acquisition-related and other costs are comprised of amortization of intangible assets, transaction costs, and certain compensation charges and are included in the following line items: | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
October 27, | July 28, | October 29, | October 27, | October 29, | ||||||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||
Cost of revenue | $ | 116 | $ | 118 | $ | 119 | $ | 355 | $ | 358 | ||||||||||||
Research and development | $ | 23 | $ | 17 | $ | 12 | $ | 52 | $ | 37 | ||||||||||||
Sales, general and administrative | $ | 16 | $ | 9 | $ | 4 | $ | 34 | $ | 51 | ||||||||||||
(B) Stock-based compensation consists of the following: | ||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||
October 27, | July 28, | October 29, | October 27, | October 29, | ||||||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||
Cost of revenue | $ | 50 | $ | 40 | $ | 38 | $ | 125 | $ | 96 | ||||||||||||
Research and development | $ | 910 | $ | 832 | $ | 701 | $ | 2,469 | $ | 1,826 | ||||||||||||
Sales, general and administrative | $ | 292 | $ | 282 | $ | 240 | $ | 822 | $ | 633 | ||||||||||||
(C) Other consists of IP-related costs and assets held for sale related adjustments | ||||||||||||||||||||||
(D) Income tax impact of non-GAAP adjustments, including the recognition of excess tax benefits or deficiencies related to stock-based compensation under GAAP accounting standard (ASU 2016-09). | ||||||||||||||||||||||
(E) Reflects a ten-for-one stock split on June 7, 2024 | ||||||||||||||||||||||
NVIDIA CORPORATION | ||||||
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK | ||||||
Q4 FY2025 Outlook |
||||||
($ in millions) | ||||||
GAAP gross margin | 73.0 | % | ||||
Impact of stock-based compensation expense, acquisition-related costs, and other costs | 0.5 | % | ||||
Non-GAAP gross margin | 73.5 | % | ||||
GAAP operating expenses | $ | 4,750 | ||||
Stock-based compensation expense, acquisition-related costs, and other costs | (1,350 | ) | ||||
Non-GAAP operating expenses | $ | 3,400 | ||||
About NVIDIA
NVIDIA NVDA is the world leader in accelerated computing.
Certain statements in this press release including, but not limited to, statements as to: the age of AI in full steam, propelling a global shift to NVIDIA computing; demand for Hopper and anticipation for Blackwell — in full production — being incredible as foundation model makers scale pretraining, post-training and inference; AI transforming every industry, company and country; enterprises adopting agentic AI to revolutionize workflows; industrial robotics investments surging with breakthroughs in physical AI; countries awakening to the importance of developing their national AI and infrastructure; NVIDIA’s next quarterly cash dividend; and NVIDIA’s financial outlook and expected tax rates for the fourth quarter of fiscal 2025 are risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; and unexpected loss of performance of our products or technologies when integrated into systems, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
© 2024 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, GeForce, NVIDIA DGX SuperPOD, NVIDIA Isaac, NVIDIA Omniverse and NVIDIA Spectrum-X are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and/or other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability and specifications are subject to change without notice.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/24a5522e-6258-4e72-9c8a-a57178db4b41
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Bitcoin Hits $95K For The First Time Ever, Ethereum, Dogecoin Flat As Trump's Crypto Policy Takes Shape: Top Analyst Describes BTC's Path To $135K
Bitcoin hit $95,000 for the first time ever, following reports of a cryptocurrency-focused role in the incoming Donald Trump administration.
Cryptocurrency | Gains +/- | Price (Recorded at 7:45 p.m. ET) |
Bitcoin BTC/USD | +2.73% | $94,794.86 |
Ethereum ETH/USD |
-0.98% | $3,083.96 |
Dogecoin DOGE/USD | -0.87% | $0.3845 |
What Happened: The leading cryptocurrency briefly surpassed the never-seen-before level overnight on Wednesday before rebounding.
With the latest uptick, Bitcoin’s weekly gains jumped to nearly 5%, while its market dominance reached 60%. Its returns for November have shot past 33% already, against the historical average of 45%.
On the contrary, Ethereum, the second-largest cryptocurrency by market capitalization, slid below $3,100. It was down over 3.5% over the week.
Bitcoin’s rally followed reports of a dedicated cryptocurrency role in Trump’s administration that would act as a bridge between the White House, Congress, and regulatory agencies like the SEC and CFTC.
Nearly $350 million in leveraged positions were liquidated from the cryptocurrency market in the last 24 hours, with long liquidations accounting for $241 million.
Bitcoin’s Open Interest (OI) surged 6.52% in the last 24 hours, implying heightened speculative interest among derivatives traders.
Most of the new bets favored Bitcoin’s price increase as the number of long positions increased vis-à-vis shorts, according to the Long/Shorts Ratio.
Market sentiment remained in the “Extreme Greed” zone, as per the Cryptocurrency Fear and Greed Index.
Top Gainers (24-Hours)
Cryptocurrency | Gains +/- | Price (Recorded at 7:45 p.m. ET) |
Floki (FLOKI) | +14.94% | $0.0002822 |
UNUS SED LEO (LEO) | +6.46% | $8.47 |
Tezos (XTZ) | +5.35% | $1.08 |
The global cryptocurrency market capitalization stood at $3.12 trillion, following an increase of 1.32% in the last 24 hours.
Stocks traded mixed on Wednesday. The S&P 500 ended the session flat, while the tech-heavy Nasdaq Composite slid 0.11% to close at 18,966.14. The Dow Jones Industrial Average
The Nasdaq Composite lifted 195.66 points, or 1.04%, to end at 18,987.47. The S&P 500 added 0.40% to close at 5,916.98. Meanwhile, the Dow Jones Industrial Average was the outlier, surging 139.53 points, or 0.32%, to end at 43,408.47.
Nvidia Corp. NVDA shares finished 0.76% lower ahead of third-quarter earnings, which eventually turned out to be better than expected.
.See More: Best Cryptocurrency Scanners
Analyst Notes: Noted cryptocurrency analyst Ali Martinez drew a parallel with Bitcoin’s Dec. 2020 trajectory, observing a “nearly identical” Relative Strength Index (RSI).
“If true, BTC will go to $108,000, drop to $99,000, and bounce to $135,000,” Martinez added.
Another widely-followed analyst, Rekt Capital, stated that Bitcoin dips from the previously broken resistance would mean a “post-breakout retest.”
“These retests aren’t always necessary but BTC’s most recent downside wicking demonstrates that there is at least retesting intent in the price action,” the analyst remarked.
Photo by SvetlanaParnikova on Shutterstock
Read Next:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Visa Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – V
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Visa Inc. V between November 16, 2023, and September 23, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 20, 2025 in the securities class action first filed by the Firm.
SO WHAT: If you purchased Visa securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Visa class action, go to https://rosenlegal.com/submit-form/?case_id=29131 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 20, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Visa was not in compliance with federal antitrust laws; (2) Visa did not have effective internal programs and policies to assess and control compliance with federal antitrust laws; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Visa class action, go to https://rosenlegal.com/submit-form/?case_id=29131 call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
——————————-
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
TM Associates and Green Street Housing Announce Grand Opening of Slippery Hill Senior and Slippery Hill, Phase II in Queenstown, MD
QUEENSTOWN, Md., Nov. 20, 2024 /PRNewswire/ — TM Associates and Green Street Housing, joined by the Maryland Department of Housing and Community Development (DHCD), Queen Anne’s County officials, partners, and community members proudly announce the grand opening of Slippery Hill Senior and Slippery Hill, Phase II. This milestone marks the completion of a decade long vision to bring 186 new affordable senior and family apartments to Queen Anne’s County.
Together with their sister community, The Village at Slippery Hill, these three phases form a dynamic, affordable living destination designed to meet the diverse needs of its residents. From thoughtful interior designs and energy-efficient features to modern amenities and a central location, these communities exemplify the best in affordable housing.
Key features include:
- Slippery Hill Senior Apartments: Spacious one- and two-bedroom homes tailored for residents 62+, serving households earning between 30% and 80% of the area’s median income.
- Slippery Hill, Phase II: A mix of one-, two-, and three-bedroom apartment homes and townhouses for families earning between 30% and 50% of the area’s median income.
- Quality finishes, including hardwood-style flooring and efficient appliances.
- Amenities such as fitness centers, eco-friendly electric vehicle charging stations, and a scenic ¾-mile walking trail.
- Convenient access to many communities on the Eastern Shore, Annapolis, Baltimore, and Washington, D.C., with on-site public transportation options.
- Proximity to local attractions like the Queenstown Outlets, restaurants, entertainment venues, and top-rated schools.
“Ever since Dave and I first stepped foot on this site in 2012, we envisioned a mixed-use intergenerational development that would provide high-quality, affordable housing in this community,” said Tom Ayd, CEO of Green Street Housing. “Seeing that vision come to life with Slippery Hill Senior and Phase II is incredibly rewarding, and we’re proud to celebrate this milestone alongside our partners and the community.”
“Slippery Hill Senior and Slippery Hill, Phase II represent a culmination of hard work and partnerships to deliver high-quality, affordable housing that enhances the lives of Maryland residents in Queen Anne’s County,” said Bob Margolis, Owner/Chief Executive Officer of TM Associates. “These communities showcase how affordable housing can be both functional and beautiful, helping to foster stability and opportunity for families and seniors alike.”
The ribbon-cutting ceremony will be held at 10am on November 21, 2024, at 320 Fallen Horse Circle. Guided tours of the new communities and light refreshments will be offered. Parking is available on-site. at 320 Fallen Horse Circle.
Prospective residents are encouraged to schedule a private tour at:
About TM Associates: TM Associates currently manages over 18,000 units across 423 properties in fourteen states plus Washington, D.C. TM Development has built or rehabilitated 7,000 affordable housing units. TM strives to deliver the best in diligence, dedication and services while effecting change in the communities they serve. This includes services such as after school programs, adult literacy and job placement, services that address food insecurities, in addition to more traditional amenities such as package acceptance, community room, and online rent payment.
TM doesn’t stop at providing new, luxury affordable housing options in urban and rural neighborhoods. Instead, TM aims to take it further and change the definition and perception of affordable housing in these neighborhoods. For more information, visit www.tmamgroup.com.
About Green Street Housing: Founded in 2008 by Dave Layfield and Tom Ayd of Salisbury, MD, Green Street Housing, LLC, is a leading affordable housing developer serving communities across Maryland, Delaware, and Virginia. With a focus on high-quality, mission-driven developments, Green Street has built a strong reputation for its expertise in Low-Income Housing Tax Credit (LIHTC) financing and public-private partnerships that create lasting community impact and navigating the complex and sometimes challenging affordable housing development process. Learn more at www.greenstreethousing.com
Contact Information:
TM Associates Management, Inc Lisa Kish lkish@tmamgroup.com |
Green Street Housing Dave Layfield dave@greenstreethousing.com |
View original content to download multimedia:https://www.prnewswire.com/news-releases/tm-associates-and-green-street-housing-announce-grand-opening-of-slippery-hill-senior-and-slippery-hill-phase-ii-in-queenstown-md-302312186.html
SOURCE TM Associates
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
VNET Reports Unaudited Third Quarter 2024 Financial Results
BEIJING, Nov. 20, 2024 /PRNewswire/ — VNET Group, Inc. VNET (“VNET” or the “Company”), a leading carrier- and cloud-neutral internet data center services provider in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.
“We achieved strong third quarter results mainly driven by our wholesale IDC business,” said Josh Sheng Chen, Founder, Executive Chairperson and interim Chief Executive Officer of VNET. “Our wholesale IDC business maintained its strong growth momentum as we capitalized on rising AI-driven demand. We also continued attracting high-quality customers during the third quarter, with six new order wins totaling 84MW. Notably, we won a new wholesale order from an Internet customer for 32MW at our Huailai IDC Campus, one of our green computing clusters in Hebei province. Moving forward, we will continue to develop our high-performance data centers and green business, providing reliable, premium IDC services to meet market demand. Propelling VNET’s high-quality, sustainable development remains our priority as we strive to deliver value to all of our stakeholders.”
Qiyu Wang, Chief Financial Officer of VNET, commented, “In the third quarter, we remained focused on high-quality revenue businesses with high margins. Our total net revenues increased by 12.4% year over year to RMB2.12 billion, mainly driven by remarkable wholesale revenue growth of 86.4% year over year. Our adjusted EBITDA also grew by 17.1% year over year to RMB594.8 million in the third quarter of 2024. We previously reported adjusted EBITDA for the third quarter of 2023 at RMB507.9 million. Such figure included VAT surplus deduction benefit of RMB13.3 million, which is now considered non-continuable due to the termination of preferential tax policies since January 1, 2024 (the “Discontinued VAT Benefits”). The year-over-year growth in adjusted EBITDA would be 20.2% if the Discontinued VAT Benefits were excluded from the adjusted EBITDA calculation for the same period last year. We also aim to enter a definitive agreement with one of China’s leading insurance companies by the end of 2024 to form a pre-REITs fund. The fund will feature the first and second phases of our Taicang IDC Campus as the underlying assets, with us retaining approximately a 51% interest in the fund. This will further strengthen our cash reserves and support our sustainable development. Looking ahead, we will continue strengthening our core capabilities and capitalizing on AI-driven opportunities to create long-term shareholder value.”
Third Quarter 2024 Financial Highlights
- Total net revenues increased by 12.4% to RMB2.12 billion (US$302.2 million) from RMB1.89 billion in the same period of 2023.
- Net revenues from the IDC business[1] increased by 18.4% to RMB1.50 billion (US$213.5 million) from RMB1.27 billion in the same period of 2023.
- Net revenues from the wholesale IDC business (“wholesale revenues”) increased by 86.4% to RMB523.0 million (US$74.5 million) from RMB280.6 million in the same period of 2023.
- Net revenues from the retail IDC business (“retail revenues”) decreased slightly by 1.0% to RMB975.5 million (US$139.0 million) from RMB984.9 million in the same period of 2023.
- Net revenues from the non-IDC business[2] increased by 0.2% to RMB622.3 million (US$88.7 million) from RMB621.4 million in the same period of 2023.
- Net revenues from the IDC business[1] increased by 18.4% to RMB1.50 billion (US$213.5 million) from RMB1.27 billion in the same period of 2023.
- Adjusted cash gross profit (non-GAAP) increased by 16.6% to RMB860.7 million (US$122.6 million) from RMB738.4 million in the same period of 2023. Adjusted cash gross margin (non-GAAP) was 40.6%, compared with 39.1% in the same period of 2023.
- Adjusted EBITDA (non-GAAP) increased by 17.1% to RMB594.8 million (US$84.8 million) from RMB507.9 million in the same period of 2023. Such figure in the third quarter of 2023 included Discontinued VAT Benefits of RMB13.3 million. The year-over-year growth in adjusted EBITDA would be 20.2% if the Discontinued VAT Benefits were excluded from the adjusted EBITDA calculation for the same period last year. Adjusted EBITDA margin (non-GAAP) was 28.0%, compared with 26.9% in the same period of 2023.
- Net income increased by RMB372.0 million and RMB260.3 million to RMB332.2 million (US$47.3 million) in the third quarter, compared with a net loss of RMB39.9 million in the same period of 2023 and a net income of RMB71.8 million in the second quarter of 2024, respectively.
Third Quarter 2024 Operational Highlights
Wholesale IDC Business[3]
- Capacity in service was 358MW as of September 30, 2024, compared with 332MW as of June 30, 2024, and 290MW as of September 30, 2023. Capacity under construction was 297MW as of September 30, 2024.
- Capacity utilized by customers reached 279MW as of September 30, 2024, compared with 252MW as of June 30, 2024, and 161MW as of September 30, 2023. The sequential increase during the third quarter of 2024 was 27MW, which was mainly contributed by the E-JS Campus 02 C data center and the N-OR06 data center.
- Utilization rate[4] of wholesale capacity was 78.0% as of September 30, 2024, compared with 75.9% as of June 30, 2024, and 55.4% as of September 30, 2023.
- Utilization rate of mature wholesale capacity[5] was 95.6% as of September 30, 2024, compared with 94.9% as of June 30, 2024, and 94.4% as of September 30, 2023.
- Utilization rate of ramp-up wholesale capacity[6] was 46.4% as of September 30, 2024, compared with 45.7% as of June 30, 2024, and 18.4% as of September 30, 2023.
- Total capacity committed[7] was 352MW as of September 30, 2024, compared with 326MW as of June 30, 2024, and 236MW as of September 30, 2023.
- Commitment rate[8] for capacity in service was 98.2% as of September 30, 2024, compared with 98.1% as of June 30, 2024, and 81.3% as of September 30, 2023.
- Total capacity pre-committed[9] was 262MW and pre-commitment rate[10] for capacity under construction was 88.4% as of September 30, 2024.
Retail IDC Business[11]
- Capacity in service was 52,250 cabinets as of September 30, 2024, compared with 52,177 cabinets as of June 30, 2024, and 52,200 cabinets as of September 30, 2023.
- Capacity utilized by customers reached 32,950 cabinets as of September 30, 2024, compared with 33,253 cabinets as of June 30, 2024, and 33,845 cabinets as of September 30, 2023.
- Utilization rate of retail capacity was 63.1% as of September 30, 2024, compared with 63.7% as of June 30, 2024, and 64.8% as of September 30, 2023.
- Utilization rate of mature retail capacity[12] was 69.5% as of September 30, 2024, compared with 72.5% as of June 30, 2024, and 73.1% as of September 30, 2023.
- Utilization rate of ramp-up retail capacity[13] was 16.8% as of September 30, 2024, compared with 12.7% as of June 30, 2024, and 18.7% as of September 30, 2023.
- Monthly recurring revenue (MRR) per retail cabinet was RMB8,788 in the third quarter of 2024, compared with RMB8,753 in the second quarter of 2024 and RMB8,845 in the third quarter of 2023.
[1] IDC business refers to managed hosting services, consisting of the wholesale IDC business and the retail IDC business. Beginning in the first quarter of 2024, our IDC business was subdivided into wholesale IDC business and retail IDC business according to the nature and scale of our data center projects. Prior to 2024, the subdivision was based on customer contract types. |
[2] Non-IDC business consists of cloud services and VPN services. |
[3] For wholesale IDC business, certain projects hosted in our E-JS02 data center with an aggregate of 27MW capacity were excluded and are expected to be continuously excluded from in-service wholesale due to pending commercial discussion with the client. Such projects were included as in-service wholesale from the first quarter of 2021 to the fourth quarter of 2023, given that such projects had been delivered to the client based on the terms of the MOU. |
[4] Utilization rate is calculated by dividing capacity utilized by customers by the capacity in service. |
[5] Mature wholesale capacity refers to wholesale data centers in which utilization rate is at or above 80%. |
[6] Ramp-up wholesale capacity refers to wholesale data centers in which utilization rate is below 80%. |
[7] Total capacity committed is the capacity committed to customers pursuant to customer agreements remaining in effect. |
[8] Commitment rate is calculated by total capacity committed divided by total capacity in service. |
[9] Total capacity pre-committed is the capacity under construction which is pre-committed to customers pursuant to customer agreements remaining in effect. |
[10] Pre-commitment rate is calculated by total capacity pre-committed divided by total capacity under construction. |
[11] For retail IDC business, since the first quarter of 2024, we have excluded a certain number of reserved cabinets from the capacity in service. Reserved cabinets refer to those that have not been utilized on a large scale, those that are planned to be closed, or those that are planned to be further upgraded. As of September 30, 2023, June 30, 2024, and September 30, 2024, 4,426, 4,150, and 4,150 reserved cabinets, respectively, were excluded from the calculation of utilization rate of retail IDC business capacity. |
[12] Mature retail capacity refers to retail data centers that came into service prior to the past 24 months. |
[13] Ramp-up retail capacity refers to retail data centers that came into service within the past 24 months, or mature retail data centers that have undergone improvements within the past 24 months. |
Third Quarter 2024 Financial Results
TOTAL NET REVENUES: Total net revenues in the third quarter of 2024 were RMB2.12 billion (US$302.2 million), representing an increase of 12.4% from RMB1.89 billion in the same period of 2023. The year-over-year increase was mainly driven by the continued growth of our wholesale IDC business.
Net revenues from IDC business increased by 18.4% to RMB1.50 billion (US$213.5 million) from RMB1.27 billion in the same period of 2023. The year-over-year increase was mainly driven by an increase in wholesale revenues.
- Wholesale revenues increased by 86.4% to RMB523.0 million (US$74.5 million) from RMB280.6 million in the same period of 2023.
- Retail revenues decreased to RMB975.5 million (US$139.0 million) from RMB984.9 million in the same period of 2023.
Net revenues from non-IDC business increased by 0.2% to RMB622.3 million (US$88.7 million) from RMB621.4 million in the same period of 2023.
GROSS PROFIT: Gross profit in the third quarter of 2024 was RMB491.7 million (US$70.1 million), representing an increase of 60.4% from RMB306.5 million in the same period of 2023. Gross margin in the third quarter of 2024 was 23.2%, compared with 16.2% in the same period of 2023. The year-over-year increase was primarily attributable to a reduction in depreciation expense due to the change in the estimated useful lives of property and equipment starting from January 1, 2024.
ADJUSTED CASH GROSS PROFIT (non-GAAP), which excludes depreciation, amortization, and share-based compensation expenses, was RMB860.7 million (US$122.6 million) in the third quarter of 2024, compared with RMB738.4 million in the same period of 2023. Adjusted cash gross margin (non-GAAP) in the third quarter of 2024 was 40.6%, compared with 39.1% in the same period of 2023.
OPERATING EXPENSES: Total operating expenses in the third quarter of 2024 were RMB300.3 million (US$42.8 million), compared with RMB274.3 million in the same period of 2023.
Sales and marketing expenses were RMB60.7 million (US$8.7 million) in the third quarter of 2024, compared with RMB64.1 million in the same period of 2023.
Research and development expenses were RMB53.1 million (US$7.6 million) in the third quarter of 2024, compared with RMB80.7 million in the same period of 2023.
General and administrative expenses were RMB132.5 million (US$18.9 million) in the third quarter of 2024, compared with RMB137.9 million in the same period of 2023.
ADJUSTED OPERATING EXPENSES (non-GAAP), which exclude share-based compensation expenses, were RMB293.6 million (US$41.8 million) in the third quarter of 2024, compared with RMB264.8 million in the same period of 2023. As a percentage of total net revenues, adjusted operating expenses (non-GAAP) in the third quarter of 2024 were 13.8%, compared with 14.0% in the same period of 2023.
ADJUSTED EBITDA (non-GAAP): Adjusted EBITDA in the third quarter of 2024 was RMB594.8 million (US$84.8 million), representing an increase of 17.1% from RMB507.9 million in the same period of 2023. Such figure in the third quarter of 2023 included Discontinued VAT Benefits of RMB13.3 million. The year-over-year growth in adjusted EBITDA would be 20.2% if the Discontinued VAT Benefits were excluded from the adjusted EBITDA calculation for the same period last year). Adjusted EBITDA margin (non-GAAP) in the third quarter of 2024 was 28.0%, compared with 26.9% in the same period of 2023.
NET INCOME/LOSS ATTRIBUTABLE TO VNET GROUP, INC.: Net income attributable to VNET Group, Inc. in the third quarter of 2024 was RMB317.6 million (US$45.3 million), compared with a net loss attributable to VNET Group, Inc. of RMB50.5 million in the same period of 2023. The year-over-year increase was mainly due to a gain in debt extinguishment.
EARNINGS PER SHARE: Basic and diluted earnings per share in the third quarter of 2024 were RMB0.20 (US$0.03) and RMB0.05 (US$0.01), respectively, which represents the equivalent to RMB1.20 (US$0.18) and RMB0.30 (US$0.06) per American depositary share (“ADS”). Each ADS represents six Class A ordinary shares. Diluted earnings per share is calculated using adjusted net income attributable to ordinary shareholders divided by the weighted average number of diluted shares outstanding.
LIQUIDITY: As of September 30, 2024, the aggregate amount of the Company’s cash and cash equivalents, restricted cash and short-term investments was RMB2.10 billion (US$298.9 million).
Total short-term debt consisting of short-term bank borrowings and the current portion of long-term borrowings was RMB1.87 billion (US$266.4 million). Total long-term debt was RMB8.88 billion (US$1.26 billion), comprised of long-term borrowings of RMB7.08 billion (US$1.0 billion) and convertible promissory notes of RMB1.79 billion (US$255.6 million).
Net cash generated from operating activities in the third quarter of 2024 was RMB760.4 million (US$108.4 million), compared with RMB454.3 million in the same period of 2023. During the third quarter of 2024, the Company obtained new debt financing, refinancing facilities and other financings of RMB0.95 billion (US$134.7 million).
Recent Development
The Company plans to sign a definitive agreement by the end of 2024 on a pre-REITs project with one of China’s leading insurance companies, under which the Company will form a pre-REITs fund (the “Fund”) to feature the first and second phases of our Taicang IDC Campus as the underlying assets with approximately 210MW total IT capacity and RMB5.74 billion estimated value.
The Company is expected to own approximately 51% interest in the Fund and sell the remaining 49% interest to the insurance company, the consideration of which would be approximately RMB1.15 billion, calculated based on the assets and liabilities of the fund at the establishment date.
After the completion of this transaction, VNET intends to consolidate the Fund for financial reporting purpose, while operating the Taicang IDC project to offer stable and premium infrastructure services. The financial results of the Fund’s underlying assets are expected to be consolidated into the Company’s financial statement.
Business Outlook
The Company increased its full year 2024 guidance for total net revenues and adjusted EBITDA. Specifically, the Company now expects total net revenues for 2024 to be between RMB8,000 million to RMB8,100 million, representing year-over-year growth of 7.9% to 9.3%, and adjusted EBITDA (non-GAAP) to be in the range of RMB2,280 million to RMB2,300 million, representing year-over-year growth of 11.8% to 12.8%. Such figure in the third quarter of 2023 adjusted EBITDA included Discontinued VAT Benefits of RMB13.3 million. The year-over-year growth in adjusted EBITDA would be 16.4% to 17.4% if the Discontinued VAT Benefits were excluded from the adjusted EBITDA calculation for the same period last year.
The forecast reflects the Company’s current and preliminary views on the market and its operational conditions and is subject to change.
Conference Call
The Company’s management will host an earnings conference call at 8:00 PM U.S. Eastern Time on Wednesday, November 20, 2024, or 9:00 AM Beijing Time on Thursday, November 21, 2024.
For participants who wish to join the call, please access the links provided below to complete the online registration process.
English line:
https://s1.c-conf.com/diamondpass/10043189-1ej64l.html
Chinese line (listen-only mode):
https://s1.c-conf.com/diamondpass/10043190-a2lrfs.html
Participants can choose between the English and Chinese options for pre-registration above. Please note that the Chinese option will be in listen-only mode. Upon registration, each participant will receive an email containing details for the conference call, including dial-in numbers, a conference call passcode and a unique access PIN, which will be used to join the conference call.
Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at http://ir.vnet.com.
A replay of the conference call will be accessible through November 28, 2024, by dialing the following numbers:
US/Canada: |
1 855 883 1031 |
Mainland China: |
400 1209 216 |
Hong Kong, China: |
800 930 639 |
International: |
+61 7 3107 6325 |
Reply PIN (English line): |
10043189 |
Reply PIN (Chinese line): |
10043190 |
Non-GAAP Disclosure
In evaluating its business, VNET considers and uses the following non-GAAP measures defined as non-GAAP financial measures by the U.S. Securities and Exchange Commission as a supplemental measure to review and assess its operating performance: adjusted cash gross profit, adjusted cash gross margin, adjusted operating expenses, adjusted EBITDA and adjusted EBITDA margin. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. For more information on these non-GAAP financial measures, please see the table captioned “Reconciliations of GAAP and non-GAAP results” set forth at the end of this press release.
The non-GAAP financial measures are provided as additional information to help investors compare business trends among different reporting periods on a consistent basis and to enhance investors’ overall understanding of the Company’s current financial performance and prospects for the future. These non-GAAP financial measures should be considered in addition to results prepared in accordance with U.S. GAAP, but should not be considered a substitute for, or superior to, U.S. GAAP results. In addition, the Company’s calculation of the non-GAAP financial measures may be different from the calculation used by other companies, and therefore comparability may be limited.
Exchange Rate
This announcement contains translations of certain RMB amounts into U.S. dollars (“USD”) at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from RMB to USD were made at the rate of RMB7.0176 to US$1.00, the noon buying rate in effect on September 30, 2024, in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or USD amounts referred could be converted into USD or RMB, as the case may be, at any particular rate or at all. For analytical presentation, all percentages are calculated using the numbers presented in the financial statements contained in this earnings release.
Statement Regarding Unaudited Condensed Financial Information
The unaudited financial information set forth above is preliminary and subject to potential adjustments. Adjustments to the consolidated financial statements may be identified when audit work has been performed for the Company’s year-end audit, which could result in significant differences from this preliminary unaudited condensed financial information.
About VNET
VNET Group, Inc. is a leading carrier- and cloud-neutral internet data center services provider in China. VNET provides hosting and related services, including IDC services, cloud services, and business VPN services to improve the reliability, security, and speed of its customers’ internet infrastructure. Customers may locate their servers and equipment in VNET’s data centers and connect to China’s internet backbone. VNET operates in more than 30 cities throughout China, servicing a diversified and loyal base of over 7,500 hosting and related enterprise customers that span numerous industries ranging from internet companies to government entities and blue-chip enterprises to small- to mid-sized enterprises.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “target,” “believes,” “estimates” and similar statements. Among other things, quotations from management in this announcement as well as VNET’s strategic and operational plans, including the plan to sign a definitive agreement on a pre-REITs project, contain forward-looking statements. VNET may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about VNET’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: VNET’s goals and strategies; VNET’s liquidity conditions; VNET’s expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, VNET’s services; VNET’s expectations regarding keeping and strengthening its relationships with customers; VNET’s plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where VNET provides solutions and services. Further information regarding these and other risks is included in VNET’s reports filed with, or furnished to, the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and VNET undertakes no duty to update such information, except as required under applicable law.
Investor Relations Contact:
Xinyuan Liu
Tel: +86 10 8456 2121
Email: ir@vnet.com
VNET GROUP, INC. |
|||||
CONSOLIDATED BALANCE SHEETS |
|||||
(Amount in thousands of Renminbi (“RMB”) and US dollars (“US$”)) |
|||||
As of |
As of |
||||
December 31, 2023 |
September 30, 2024 |
||||
RMB |
RMB |
US$ |
|||
Assets |
|||||
Current assets: |
|||||
Cash and cash equivalents |
2,243,537 |
1,524,819 |
217,285 |
||
Restricted cash |
2,854,568 |
556,266 |
79,267 |
||
Accounts and notes receivable, net |
1,715,975 |
1,861,828 |
265,308 |
||
Short-term Investments |
356,820 |
15,879 |
2,263 |
||
Prepaid expenses and other current assets |
2,375,341 |
2,665,924 |
379,891 |
||
Amounts due from related parties |
277,237 |
317,619 |
45,260 |
||
Total current assets |
9,823,478 |
6,942,335 |
989,274 |
||
Non-current assets: |
|||||
Property and equipment, net |
13,024,393 |
15,153,253 |
2,159,321 |
||
Intangible assets, net |
1,383,406 |
1,347,751 |
192,053 |
||
Land use rights, net |
602,503 |
588,846 |
83,910 |
||
Operating lease right-of-use assets, net |
4,012,329 |
4,412,834 |
628,824 |
||
Restricted cash |
882 |
882 |
126 |
||
Deferred tax assets, net |
247,644 |
309,390 |
44,088 |
||
Long-term investments, net |
757,949 |
798,638 |
113,805 |
||
Other non-current assets |
533,319 |
371,501 |
52,938 |
||
Total non-current assets |
20,562,425 |
22,983,095 |
3,275,065 |
||
Total assets |
30,385,903 |
29,925,430 |
4,264,339 |
||
Liabilities and Shareholders’ Equity |
|||||
Current liabilities: |
|||||
Short-term bank borrowings |
30,000 |
552,270 |
78,698 |
||
Accounts and notes payable |
696,177 |
728,361 |
103,791 |
||
Accrued expenses and other payables |
2,783,102 |
2,527,584 |
360,178 |
||
Advances from customers |
1,605,247 |
1,752,935 |
249,791 |
||
Deferred revenue |
95,477 |
87,354 |
12,448 |
||
Income taxes payable |
35,197 |
51,554 |
7,346 |
||
Amounts due to related parties |
356,080 |
354,903 |
50,573 |
||
Current portion of long-term borrowings |
723,325 |
1,317,343 |
187,720 |
||
Current portion of finance lease liabilities |
115,806 |
107,785 |
15,359 |
||
Current portion of deferred government grants |
8,062 |
8,538 |
1,217 |
||
Current portion of operating lease liabilities |
780,164 |
874,957 |
124,680 |
||
Convertible promissory notes |
4,208,495 |
– |
– |
||
Total current liabilities |
11,437,132 |
8,363,584 |
1,191,801 |
||
Non-current liabilities: |
|||||
Long-term borrowings |
5,113,521 |
7,082,026 |
1,009,181 |
||
Convertible promissory notes |
1,769,946 |
1,793,894 |
255,628 |
||
Non-current portion of finance lease liabilities |
1,159,525 |
1,169,573 |
166,663 |
||
Unrecognized tax benefits |
98,457 |
98,457 |
14,030 |
||
Deferred tax liabilities |
688,362 |
703,390 |
100,232 |
||
Deferred government grants |
145,112 |
265,941 |
37,896 |
||
Non-current portion of operating lease liabilities |
3,270,759 |
3,587,701 |
511,243 |
||
Derivative liability |
188,706 |
– |
– |
||
Total non-current liabilities |
12,434,388 |
14,700,982 |
2,094,873 |
||
Shareholders’ equity |
|||||
Ordinary shares |
107 |
109 |
16 |
||
Additional paid-in capital |
17,291,312 |
17,256,955 |
2,459,096 |
||
Accumulated other comprehensive loss |
(14,343) |
(16,088) |
(2,293) |
||
Statutory reserves |
80,615 |
94,276 |
13,434 |
||
Accumulated deficit |
(11,016,323) |
(10,835,688) |
(1,544,073) |
||
Treasury stock |
(326,953) |
(163,073) |
(23,238) |
||
Total VNET Group, Inc. shareholders’ equity |
6,014,415 |
6,336,491 |
902,942 |
||
Noncontrolling interest |
499,968 |
524,373 |
74,723 |
||
Total shareholders’ equity |
6,514,383 |
6,860,864 |
977,665 |
||
Total liabilities and shareholders’ equity |
30,385,903 |
29,925,430 |
4,264,339 |
VNET GROUP, INC. |
||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||
(Amount in thousands of Renminbi (“RMB”) and US dollars (“US$”) except for number of shares and per share data) |
||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||
September 30, 2023 |
June 30, 2024 |
September 30, 2024 |
September 30, 2023 |
September 30, 2024 |
||||||||||
RMB |
RMB |
RMB |
US$ |
RMB |
RMB |
US$ |
||||||||
Net revenues |
1,886,924 |
1,993,760 |
2,120,794 |
302,211 |
5,514,450 |
6,012,680 |
856,800 |
|||||||
Cost of revenues |
(1,580,446) |
(1,568,865) |
(1,629,111) |
(232,146) |
(4,512,843) |
(4,685,381) |
(667,661) |
|||||||
Gross profit |
306,478 |
424,895 |
491,683 |
70,065 |
1,001,607 |
1,327,299 |
189,139 |
|||||||
Operating income (expenses) |
||||||||||||||
Operating income |
26,706 |
– |
11,767 |
1,677 |
73,980 |
15,716 |
2,240 |
|||||||
Sales and marketing expenses |
(64,077) |
(58,225) |
(60,700) |
(8,650) |
(192,921) |
(190,668) |
(27,170) |
|||||||
Research and development expenses |
(80,673) |
(61,998) |
(53,127) |
(7,571) |
(241,549) |
(190,514) |
(27,148) |
|||||||
General and administrative expenses |
(137,931) |
(107,297) |
(132,482) |
(18,879) |
(393,395) |
(466,076) |
(66,415) |
|||||||
Allowance for doubtful debt |
(18,316) |
(2,753) |
(65,731) |
(9,367) |
(7,034) |
(63,309) |
(9,021) |
|||||||
Total operating expenses |
(274,291) |
(230,273) |
(300,273) |
(42,790) |
(760,919) |
(894,851) |
(127,514) |
|||||||
Operating profit |
32,187 |
194,622 |
191,410 |
27,275 |
240,688 |
432,448 |
61,625 |
|||||||
Interest income |
12,887 |
5,449 |
4,218 |
601 |
28,606 |
21,796 |
3,106 |
|||||||
Interest expense |
(91,800) |
(92,172) |
(93,996) |
(13,394) |
(233,295) |
(323,850) |
(46,148) |
|||||||
Impairment of long-term investments |
(11,115) |
– |
– |
– |
(11,115) |
– |
– |
|||||||
Other income |
7,536 |
30,475 |
15,584 |
2,221 |
22,892 |
50,873 |
7,249 |
|||||||
Other expenses |
(10,975) |
(6,900) |
(8,783) |
(1,252) |
(14,887) |
(17,105) |
(2,437) |
|||||||
Changes in the fair value of financial liabilities |
266 |
712 |
(7,107) |
(1,013) |
21,718 |
(2,537) |
(362) |
|||||||
Gain on debt extinguishment |
– |
– |
246,175 |
35,080 |
– |
246,175 |
35,080 |
|||||||
Foreign exchange gain (loss) |
24,606 |
(4,387) |
14,833 |
2,114 |
(168,391) |
(17,915) |
(2,553) |
|||||||
(Loss) income before income taxes and gain from equity method investments |
(36,408) |
127,799 |
362,334 |
51,632 |
(113,784) |
389,885 |
55,560 |
|||||||
Income tax expenses |
(6,317) |
(59,149) |
(31,149) |
(4,439) |
(63,748) |
(151,682) |
(21,615) |
|||||||
Gain from equity method investments |
2,842 |
3,199 |
965 |
138 |
3,651 |
6,770 |
965 |
|||||||
Net (loss) income |
(39,883) |
71,849 |
332,150 |
47,331 |
(173,881) |
244,973 |
34,910 |
|||||||
Net income attributable to noncontrolling interest |
(10,579) |
(8,174) |
(14,524) |
(2,070) |
(27,167) |
(50,677) |
(7,221) |
|||||||
Net (loss) income attributable to the VNET Group, Inc. |
(50,462) |
63,675 |
317,626 |
45,261 |
(201,048) |
194,296 |
27,689 |
|||||||
(Loss) earnings per share |
||||||||||||||
Basic |
(0.06) |
0.04 |
0.20 |
0.03 |
(0.23) |
0.12 |
0.02 |
|||||||
Diluted |
(0.06) |
0.04 |
0.05 |
0.01 |
(0.24) |
(0.02) |
(0.00) |
|||||||
Shares used in (loss) earnings per share computation |
||||||||||||||
Basic* |
889,058,872 |
1,594,662,099 |
1,602,860,426 |
1,602,860,426 |
888,724,901 |
1,588,659,647 |
1,588,659,647 |
|||||||
Diluted* |
889,058,872 |
1,595,517,338 |
1,740,565,086 |
1,740,565,086 |
899,884,241 |
1,725,023,283 |
1,725,023,283 |
|||||||
(Loss) earnings per ADS (6 ordinary shares equal to 1 ADS) |
||||||||||||||
Basic |
(0.36) |
0.24 |
1.20 |
0.18 |
(1.38) |
0.72 |
0.12 |
|||||||
Diluted |
(0.36) |
0.24 |
0.30 |
0.06 |
(1.44) |
(0.12) |
(0.02) |
|||||||
* Shares used in (loss) earnings per share/ADS computation were computed under weighted average method. |
VNET GROUP, INC. |
||||||||||||||
RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS |
||||||||||||||
(Amount in thousands of Renminbi (“RMB”) and US dollars (“US$”)) |
||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||
September 30, 2023 |
June 30, 2024 |
September 30, 2024 |
September 30, 2023 |
September 30, 2024 |
||||||||||
RMB |
RMB |
RMB |
US$ |
RMB |
RMB |
US$ |
||||||||
Gross profit |
306,478 |
424,895 |
491,683 |
70,065 |
1,001,607 |
1,327,299 |
189,139 |
|||||||
Plus: depreciation and amortization |
431,933 |
364,616 |
368,764 |
52,548 |
1,233,983 |
1,085,984 |
154,751 |
|||||||
Plus: share-based compensation expenses |
– |
(2,190) |
234 |
33 |
– |
234 |
33 |
|||||||
Adjusted cash gross profit |
738,411 |
787,321 |
860,681 |
122,646 |
2,235,590 |
2,413,517 |
343,923 |
|||||||
Adjusted cash gross margin |
39.1 % |
39.5 % |
40.6 % |
40.6 % |
40.5 % |
40.1 % |
40.1 % |
|||||||
Operating expenses |
(274,291) |
(230,273) |
(300,273) |
(42,790) |
(760,919) |
(894,851) |
(127,514) |
|||||||
Plus: share-based compensation expenses |
9,475 |
(12,962) |
6,709 |
956 |
25,817 |
105,428 |
15,023 |
|||||||
Adjusted operating expenses |
(264,816)* |
(243,235) |
(293,564) |
(41,834) |
(735,102) |
(789,423) |
(112,491) |
|||||||
Operating profit |
32,187* |
194,622 |
191,410 |
27,275 |
240,688 |
432,448 |
61,625 |
|||||||
Plus: depreciation and amortization |
466,285 |
394,334 |
396,428 |
56,491 |
1,332,649 |
1,170,313 |
166,768 |
|||||||
Plus: share-based compensation expenses |
9,475 |
(15,152) |
6,943 |
989 |
25,817 |
105,662 |
15,057 |
|||||||
Adjusted EBITDA |
507,947* |
573,804 |
594,781 |
84,755 |
1,599,154 |
1,708,423 |
243,450 |
|||||||
Adjusted EBITDA margin |
26.9 % |
28.8 % |
28.0 % |
28.0 % |
29.0 % |
28.4 % |
28.4 % |
|||||||
* Included VAT surplus deduction benefit of RMB13.3 million, which is now considered non-continuable due to the termination of preferential tax policies since January 1, 2024. |
VNET GROUP, INC. |
|||||||
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS |
|||||||
(Amount in thousands of Renminbi (“RMB”) and US dollars (“US$”)) |
|||||||
Three months ended |
|||||||
September 30, 2023 |
June 30, 2024 |
September 30, 2024 |
|||||
RMB |
RMB |
RMB |
US$ |
||||
CASH FLOWS FROM OPERATING ACTIVITIES |
|||||||
Net (loss) income |
(39,883) |
71,849 |
332,150 |
47,331 |
|||
Adjustments to reconcile net (loss) income to net cash generated from operating activities: |
|||||||
Depreciation and amortization |
461,603 |
388,711 |
393,719 |
56,105 |
|||
Share-based compensation expenses |
9,475 |
(15,152) |
6,943 |
989 |
|||
Others |
130,633 |
101,890 |
(107,550) |
(15,326) |
|||
Changes in operating assets and liabilities |
|||||||
Accounts and notes receivable |
(70,896) |
142,469 |
(138,968) |
(19,803) |
|||
Prepaid expenses and other current assets |
(48,380) |
(79,893) |
116,055 |
16,538 |
|||
Accounts and notes payable |
21,763 |
(47,018) |
8,463 |
1,206 |
|||
Accrued expenses and other payables |
(54,577) |
(61,463) |
65,481 |
9,329 |
|||
Deferred revenue |
36,008 |
(14,000) |
2,300 |
328 |
|||
Advances from customers |
124,816 |
(63,305) |
222,083 |
31,647 |
|||
Others |
(116,249) |
(18,884) |
(140,310) |
(19,994) |
|||
Net cash generated from operating activities |
454,313 |
405,204 |
760,366 |
108,350 |
|||
CASH FLOWS FROM INVESTING ACTIVITIES |
|||||||
Purchases of property and equipment |
(946,444) |
(998,489) |
(1,426,892) |
(203,330) |
|||
Purchases of intangible assets |
(18,228) |
(7,594) |
(33,806) |
(4,817) |
|||
Proceeds from (payments for) investments |
144,516 |
(138,224) |
92,426 |
13,171 |
|||
Proceeds from other investing activities |
70,010 |
117,209 |
31,762 |
4,526 |
|||
Net cash used in investing activities |
(750,146) |
(1,027,098) |
(1,336,510) |
(190,450) |
|||
CASH FLOWS FROM FINANCING ACTIVITIES |
|||||||
Proceeds from bank borrowings |
756,101 |
690,848 |
745,534 |
106,238 |
|||
Repayments of bank borrowings |
(78,050) |
(533,324) |
(129,893) |
(18,510) |
|||
Repayments of 2025 Convertible Notes |
(148,842) |
– |
– |
– |
|||
Payments for finance leases |
(30,366) |
(9,586) |
(27,669) |
(3,943) |
|||
Proceeds from (payments for) other financing activities |
216,711 |
516,493 |
(59,645) |
(8,499) |
|||
Net cash generated from financing activities |
715,554 |
664,431 |
528,327 |
75,286 |
|||
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash |
(12,476) |
3,370 |
(6,049) |
(862) |
|||
Net increase (decrease) in cash, cash equivalents and restricted cash |
407,245 |
45,907 |
(53,866) |
(7,676) |
|||
Cash, cash equivalents and restricted cash at beginning of period |
2,616,969 |
2,089,926 |
2,135,833 |
304,354 |
|||
Cash, cash equivalents and restricted cash at end of period |
3,024,214 |
2,135,833 |
2,081,967 |
296,678 |
View original content:https://www.prnewswire.com/news-releases/vnet-reports-unaudited-third-quarter-2024-financial-results-302311297.html
SOURCE VNET Group, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Palo Alto Networks Q1 Earnings: Revenue Beat, EPS Beat, 2-For-1 Stock Split, 'Multiyear' Platformization Trend For Security, AI
Palo Alto Networks Inc PANW reported financial results for the first quarter of fiscal 2025 after the bell on Wednesday. Here’s a look at the key details from the quarter.
Q1 Earnings: Palo Alto reported first-quarter revenue of $2.14 billion, beating the consensus estimate of $2.12 billion. The cybersecurity company reported quarterly earnings of $1.56 per share, beating analyst estimates of $1.48 per share, according to Benzinga Pro.
Total revenue was up 14% year-over-year. Remaining performance obligations grew 20% year-over-year to $12.6 billion. Next-generation security annual recurring revenue increased 40% year-over-year to $4.5 billion.
“Our Q1 results reinforced our conviction in our differentiated platformization strategy,” said Nikesh Arora, chairman and CEO of Palo Alto Networks.
“We see a growing market realization that platformization is the game changer that will solve security and enable better AI outcomes. I expect this will be a multiyear trend for which we are best positioned to deliver to our customers.”
See Also: Fed’s Bowman Warns On Inflation, Says Neutral Interest Rates May Be Closer ‘Than We Currently Think’
Palo Alto also announced that its board approved a two-for-one forward stock split. Shareholders of record as of Dec. 12 will receive one additional share for each share held after the market close on Dec. 13. The stock is expected to start trading on a split-adjusted basis on Dec. 16.
Guidance: Palo Alto expects fiscal second-quarter revenue to be in the range of $2.22 billion to $2.25 billion versus estimates of $2.23 billion. The company expects second-quarter adjusted earnings to be between $1.54 and $1.56 per share versus estimates of $1.55 per share.
Palo Alto expects full-year 2025 revenue to be between $9.12 billion and $9.17 billion versus estimates of $9.13 billion. The company anticipates full-year earnings between $6.26 and $6.39 per share versus estimates of $6.28 per share.
Palo Alto executives will hold a call with analysts and investors at 4:30 p.m. ET to further discuss the company’s quarterly results.
PANW Price Action: Palo Alto shares were down 5.83% in after-hours, trading at $371.40 at the time of writing, according to Benzinga Pro.
Read Next:
Photo: Shutterstock.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Waldencast Reports Q3 2024 Financial Results
$70.2 million of Net Revenue Q3 2024
+34.6% Comparable Net Revenue Growth
Both brands accelerating from Q2 2024
+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023
Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023
LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) — Waldencast plc WALD (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 (“Q3 2024”) and nine months ended September 30, 2024 (“Nine Months 2024”) on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company’s investor relations site at http://ir.waldencast.com/.
Michel Brousset, Waldencast Founder and CEO, said: “We are pleased to report another quarter of strong results, with Comparable Net Revenue Growth of 34.6% and continued gross margin and Adjusted EBITDA expansion. This reflects the strength of both our Obagi Medical and Milk Makeup brands, driven by increased consumer demand, the introduction of strong innovation in both brands, and improved stock availability. In Q3 2024, our Adjusted EBITDA Margin rose to 16.3%, a 720-basis point improvement over last year. We are confident in our ability to deliver on our guidance of full year Comparable Net Revenue Growth above the 25.7% growth achieved in the second quarter while delivering Adjusted EBITDA Margin in the mid-teens as we continue to leverage the power of our Waldencast platform to drive growth and enhance profitability of our market leading brands.”
Q3 2024 Results Overview & FY 2024 Outlook
Please refer to the definitions and reconciliations set out further in this release with respect to certain adjusted non-GAAP measures discussed below which are included to provide an easier understanding of the underlying performance of the business, but should not be seen as a substitute for the U.S. GAAP numbers presented in this release.
For the three months ended September 30, 2024 compared to the three months ended September 30, 2023:
Net Revenue for Q3 2024 was $70.2 million, a +30.8% increase on a net revenue basis and a +34.6% increase in Comparable Net Revenue Growth. This strong performance reflects the impact of our strategic focus on strengthening the brand equity of both Milk Makeup and Obagi Medical, accelerating the pace of innovation, and expanding the reach of both brands domestically and internationally.
Gross Profit was $48.1 million, compared to Gross Profit of $35.9 million in Q3 2023. Adjusted Gross Profit was $51.4 million, or 73.2% of net revenue, a 400-basis point increase. This increase was driven by growth in higher-margin digital channels, lower inventory adjustments, and product mix.
Net Loss improved from $36.5 million in Q3 2023 to $13.1 million in Q3 2024, driven by improvements in Adjusted Gross Margin, and fair value adjustment for warrants.
Adjusted EBITDA for Q3 2023 was $11.4 million, compared with $4.9 million in Q3 2024, an increase of 134.0%. Adjusted EBITDA Margin was 16.3% of net revenue, a 720-basis point expansion reflecting sales growth and strong operational leverage that has more than offset increased investment in marketing, and the international structure we put in place to support growth.
Liquidity: The business maintained strong cash conversion during Q3 2024 supported by effective working capital management and limited capital expenditure thanks to our asset light business model. However, the Company continues to incur significant non-recurring costs associated with legal and advisory fees. As of September 30, 2024, the Group had $17.6 million in cash and cash equivalents and $154.0 million of Net Debt. In addition, $30 million remains undrawn on the Company’s $45 million revolving credit facility as of September 30, 2024.
Outstanding Shares: As of November 15, 2024, the Company had 122,850,904 ordinary shares outstanding, consisting of 112,084,376 Class A ordinary shares outstanding and 10,766,528 Class B ordinary shares outstanding. As of December 31, 2023, the Company had 122,076,410 ordinary shares outstanding, consisting of 101,228,857 Class A ordinary shares outstanding, and 20,847,553 Class B ordinary shares outstanding. Fully Diluted Shares decreased from 129,695,296 at December 31, 2023 to 128,328,987 as of November 15, 2024, primarily driven by forfeitures of unvested shares and lower in-the-money dilutive instruments. All contractual lock-ups with shareholders have now expired.
Fiscal 2024 Outlook: We expect to deliver on our guidance of full year Comparable Net Revenue Growth above the 25.7% growth achieved in the second quarter while delivering Adjusted EBITDA Margin in the mid-teens.
(In millions, except for percentages) | Q3 2024 | % Sales | % Growth | % Comp Growth | Q3 2023 | % Sales | |||||||
Waldencast | |||||||||||||
Net Revenue | 70.2 | 100.0% | 30.8% | 34.6% | 53.7 | 100.0% | |||||||
Adjusted Gross Profit | 51.4 | 73.2% | 38.3% | 37.2 | 69.2% | ||||||||
Adjusted EBITDA | 11.4 | 16.3% | 134.0% | 4.9 | 9.1% | ||||||||
Obagi Medical | |||||||||||||
Net Revenue | 38.7 | 100.0% | 37.4% | 45.5% | 28.2 | 100.0% | |||||||
Adjusted Gross Profit | 30.4 | 78.6% | 57.6% | 19.3 | 68.5% | ||||||||
Adjusted EBITDA | 7.5 | 19.3% | 129.7% | 3.3 | 11.6% | ||||||||
Milk Makeup | |||||||||||||
Net Revenue | 31.5 | 100.0% | 23.5% | 25.5 | 100.0% | ||||||||
Adjusted Gross Profit | 21.0 | 66.6% | 17.5% | 17.9 | 70.0% | ||||||||
Adjusted EBITDA | 8.5 | 27.1% | 99.6% | 4.3 | 16.7% | ||||||||
Obagi Medical:
- Net Revenue reached $38.7 million vs $28.2 million in Q3 2023 with Comparable Net Revenue Growth of 45.5%, and Adjusted EBITDA of $7.5 million, a 129.7% increase from Q3 2023.
- The robust net revenue growth for Obagi Medical was driven by: 1) the continued growth of our brand awareness supported by stronger selling and marketing investments; 2) our continued strong innovation including the launch of the power duo of Elastiderm Lift Up & Sculpt Facial Moisturizer and Advanced Filler Concentrate, which helped lift the rest of our Elastiderm franchise; 3) the growth of the brand’s distribution footprint through our continued international expansion, and the acceleration of our digital channels through the expansion of our direct-to-consumer channel capabilities as well as the business model optimization of our main e-commerce business partner. This business model optimization benefit, which resulted from the internalization of this distribution channel in 2023 will normalize in subsequent quarters.
- The U.S. physician dispensed channel returned to growth in Q3 2024 due to better stock levels of key products. Additionally, although we saw improved stock availability in the quarter, out-of-stocks continue to impact select key products in the short-term, with further progress expected in Q4 2024 to support domestic and international expansion.
- Adjusted Gross Margin increased 1,010-basis points to 78.6% compared to Q3 2023, due to a more favorable channel mix and other sourcing and operational efficiency initiatives.
- Adjusted EBITDA Margin rose by 770-basis points to 19.3%, up from 11.6% in Q3 2023.
Milk Makeup:
- Net Revenue reached $31.5 million, up 23.5%, and Adjusted EBITDA of $8.5 million, which doubled from Q3 2023.
- Milk Makeup’s brand momentum continues through 1) increased brand awareness and strong consumer engagement; 2) continued expansion of the brand distribution footprint with the addition of four new European retailers in 2024; and 3) new launches in the quarter building on the success of the Cooling Water Jelly Tints, with the introduction of two additional Jelly Tint shades and the launch of Hydro Grip + Glow and Kush High Roller brow and mascara, further strengthening our product offering.
- Adjusted Gross Margin decreased by 340-basis points versus Q3 2023, primarily due to seasonal product mix shift toward lower margin holiday promotional kits and higher off-price channel sales, as well as an inventory provision release in Q3 2023.
- Adjusted EBITDA Margin improved from 16.7% in Q3 2023 to 27.1% in Q3 2024.
Nine Months 2024 Results Overview
For the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023:
Net Revenue was $201.8 million, compared to net revenue of $163.0 million in the Nine Months 2023, a +23.8% increase on a net revenue basis and a +26.9% increase in Comparable Net Revenue Growth.
Gross Profit was $142.3 million, compared to Gross Profit of $104.1 million in the Nine Months 2023. Adjusted Gross Profit was $150.9 million, or 74.8% of net revenue, a margin improvement of 720-basis points.
Net Loss was $26.1 million, compared to a Net Loss of $73.2 million in the Nine Months 2023. Net loss improved primarily due to income related to the fair value adjustment for warrants.
Adjusted EBITDA was $29.1 million, or Adjusted EBITDA Margin of 14.4%, compared to 11.5% in the Nine Months 2023.
Nine Months 2024 Highlights
(In millions, except for percentages) | Nine Months 2024 | % Sales | % Growth | % Comp Growth | Nine Months 2023 | % Sales | |||||||
Waldencast | |||||||||||||
Net Revenue | 201.8 | 100.0% | 23.8% | 26.9% | 163.0 | 100.0% | |||||||
Adjusted Gross Profit | 150.9 | 74.8% | 37.0% | 110.1 | 67.6% | ||||||||
Adjusted EBITDA | 29.1 | 14.4% | 54.9% | 18.8 | 11.5% | ||||||||
Obagi Medical | |||||||||||||
Net Revenue | 107.1 | 100.0% | 25.7% | 32.0% | 85.2 | 100.0% | |||||||
Adjusted Gross Profit | 85.3 | 79.7% | 47.8% | 57.8 | 67.8% | ||||||||
Adjusted EBITDA | 20.7 | 19.3% | 60.5% | 12.9 | 15.1% | ||||||||
Milk Makeup | |||||||||||||
Net Revenue | 94.7 | 100.0% | 21.7% | 77.8 | 100.0% | ||||||||
Adjusted Gross Profit | 65.6 | 69.2% | 25.2% | 52.4 | 67.3% | ||||||||
Adjusted EBITDA | 24.2 | 25.6% | 42.5% | 17.0 | 21.9% | ||||||||
Conference Call and Webcast Information
Waldencast will host a conference call to discuss its third quarter results for the period ended September 30, 2024, Thursday, November 21, 2024, at 8:30 AM ET. Those interested in participating in the conference call are invited to dial (877) 704-4453. International callers may dial (201) 389-0920. A live webcast of the conference call will include a slide presentation and will be available online at https://ir.waldencast.com/. A replay of the webcast will remain available on the website until the Company’s next conference call. The information accessible on, or through, our website is not incorporated by reference into this release.
Non-GAAP Financial Measures
In addition to the financial measures presented in this release in accordance with U.S. GAAP, Waldencast separately reports financial results on the basis of the measures set out and defined below which are non-GAAP financial measures. Waldencast believes the non-GAAP measures used in this release provide useful information to management and investors regarding certain financial and business trends relating to its financial condition and results of operations. Waldencast believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends. These non-GAAP measures also provide perspective on how Waldencast’s management evaluates and monitors the performance of the business.
There are limitations to non-GAAP financial measures because they exclude charges and credits that are required to be included in GAAP financial presentation. The items excluded from GAAP financial measures such as net income/loss to arrive at non-GAAP financial measures are significant components for understanding and assessing our financial performance. Non-GAAP financial measures should be considered together with, and not alternatives to, financial measures prepared in accordance with GAAP.
Please refer to definitions set out in the release and the tables included in this release for a reconciliation of these metrics to the most directly comparable GAAP financial measures.
Comparable Net Revenue is defined as Net Revenue excluding sales related to the former Obagi Medical China business, which was not acquired by Waldencast at the time of the Business Combination (the “Obagi Medical China Business”) as was presented in previous earnings releases. The sales to the Obagi Medical China business have a below market sales price for a defined period of time after the acquisition of Obagi Medical. As a result of the acquisition, a below market contract liability was recognized and is amortized based on sales. This adjustment is shown in the Adjusted EBITDA reconciliation. Management believes that this non-GAAP measures provides perspective on how Waldencast’s management evaluates and monitors the performance of the business. See reconciliation to U.S. GAAP Net Revenue in the Appendix.
Comparable Net Revenue Growth is defined as the growth in Comparable Net Revenue period over period expressed as a percentage.
Adjusted Gross Profit is defined as GAAP gross profit excluding the impact of inventory fair value adjustments, amortization of the supply agreement and formulation intangible assets, discontinued product write-off, and the amortization of the fair value of the related party liability the Obagi Medical China Business. The Adjusted Gross Profit reconciliation by Segment for each period is included in the Appendix.
Adjusted Gross Margin is defined as Adjusted Gross Profit divided by GAAP Net Revenue.
Adjusted EBITDA is defined as GAAP net income (loss) before interest income or expense, income tax (benefit) expense, depreciation and amortization, and further adjusted for the items as described in the reconciliation below. We believe this information will be useful for investors to facilitate comparisons of our operating performance and better identify trends in our business. Adjusted EBITDA excludes certain expenses that are required to be presented in accordance with GAAP because management believes they are non-core to our regular business. These include non-cash expenses, such as depreciation and amortization, stock-based compensation, inventory fair value adjustments, the amortization of fair value of the related party liability to the Obagi Medical China Business, change in fair value of financial instruments, loss on impairment of leases, and foreign currency transaction loss (gain). In addition, adjustments include expenses that are not related to our underlying business performance including (1) legal, advisory and consultant fees related to the financial restatement of previously issued financial statements and associated regulatory investigation; (2) costs to recover and the value of the inventory recovered from the acquisition of the Vietnam distributor, and the associated discontinued product; and (3) other non-recurring costs, primarily legal settlement costs and restructuring costs. The Adjusted EBITDA by Segment for each period is included in the Appendix.
Adjusted EBITDA Margin is defined as Adjusted EBITDA as a percentage of net revenue. The Adjusted EBITDA Margin reconciliation by Segment for each period is included in the Appendix.
(In thousands, except for percentages) | Three Months Ended September 30, 2024 | Three Months Ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||
Net Loss | $ | (13,145 | ) | $ | (36,456 | ) | $ | (26,051 | ) | $ | (73,237 | ) | ||||
Adjusted For: | ||||||||||||||||
Depreciation and amortization | 14,989 | 15,374 | 45,002 | 45,635 | ||||||||||||
Interest expense, net | 4,355 | 5,001 | 13,067 | 14,613 | ||||||||||||
Income tax expense (benefit) | (1,649 | ) | (1,490 | ) | (4,003 | ) | (5,999 | ) | ||||||||
Stock-based compensation expense | 1,872 | 2,080 | 6,399 | 7,558 | ||||||||||||
Legal and advisory non-recurring costs(1) | 8,026 | 9,211 | 18,465 | 19,834 | ||||||||||||
Change in fair value of warrants and interest rate collar | (3,390 | ) | 9,437 | (24,122 | ) | 7,970 | ||||||||||
Amortization of related party liability(2) | (732 | ) | (1,687 | ) | (1,510 | ) | (4,058 | ) | ||||||||
Other costs(3) | 1,089 | 3,409 | 1,852 | 6,467 | ||||||||||||
Adjusted EBITDA | 11,415 | 4,879 | 29,099 | 18,783 | ||||||||||||
Net Revenue | $ | 70,203 | $ | 53,683 | $ | 201,785 | $ | 163,021 | ||||||||
Net Loss % of Net Revenue | (18.7 | )% | (67.9 | )% | (12.9 | )% | (44.9 | )% | ||||||||
Adjusted EBITDA Margin | 16.3 | % | 9.1 | % | 14.4 | % | 11.5 | % |
(1) | Includes mainly legal, advisory and consultant fees related to the financial restatement for FY 2022 and associated regulatory investigation. | |
(2) | Relates to the fair value of the related party liability for the unfavorable discount to the Obagi Medical China Business as part of the Business Combination. | |
(3) | Other costs include the amortization of the fair value step-up as a result of the business combination, legal settlements, foreign currency transaction losses, the cost and gain of the recovery of inventory from the Vietnam distributor, product discontinuation costs related to advanced purchases for the Vietnam distributor, lease impairments and restructuring costs. | |
Net Debt Position is defined as the principal outstanding for the 2022 Term Loan and 2022 Revolving Credit Facility minus the cash and cash equivalents as of September 30, 2024.
(In thousands) | Reconciliation of Net Carrying Amount of debt to Net Debt | |||
Current portion of long-term debt | $ | 27,699 | ||
Long-term debt | 141,213 | |||
Net carrying amount of debt | 168,912 | |||
Adjustments: | ||||
Add: Unamortized debt issuance costs | 2,715 | |||
Less: Cash & cash equivalents | (17,648 | ) | ||
Net Debt | $ | 153,979 | ||
About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.
Obagi Medical is an industry-leading, advanced skin care line rooted in research and skin biology, refined with a legacy of 35 years’ experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Medical Nu-Derm® System, Obagi Medical products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. More information about Obagi Medical is available on the brand’s website at www.obagi.com.
Founded in 2016, Milk Makeup quickly became a cult-favorite among the beauty community for its values of self-expression and inclusion, captured by its signature Live Your Look, its innovative formulas and clean ingredients. The brand creates vegan, cruelty-free, clean formulas from its Milk Makeup HQ in Downtown NYC. Currently, Milk Makeup offers over 300 products through its U.S. website www.MilkMakeup.com, and its retail partners including Sephora in North America, Europe, the Middle East and Australia and Cult Beauty and Selfridges in the UK.
Cautionary Statement Regarding Forward-Looking Statements
All statements in this release that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about: statements regarding Waldencast’s outlook and guidance for Q4 2024 and Fiscal 2024, the Company’s ability to deliver financial results in line with expectations; expectations regarding sales, earnings or other future financial performance and liquidity or other performance measures; the Company’s long-term strategy and future operations or operating results; expectations with respect to the Company’s industry and the markets in which it operates; future product introductions; developments relating to the ongoing investigation and legal proceedings; and any assumptions underlying any of the foregoing. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” and “will” and variations of such words and similar expressions are intended to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the Company, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements, including, among others: (i) the inability to recognize the anticipated benefits of the business combination with Obagi Medical and Milk Makeup, (ii) the ability of the Company to file required financial results in a timely manner, (iii) the Company’s ability to successfully remediate the material weaknesses in the Company’s internal control over financial reporting, (iv) the potential for delisting, legal proceedings or existing or new government investigation or enforcement actions, including those relating to the restatement or the subject of the Audit Committee of the Company’s Board of Directors’ review further described in the Company’s annual report filed on Form 20-F for the year ended December 31, 2022 or inability to finalize financial results in a timely manner, (v) the Company’s ability to obtain additional waivers from the Administrative Agent and the lenders under its credit facilities for any defaults or events of default, (vi) volatility of Waldencast’s securities due to a variety of factors, including Waldencast’s inability to implement its business plans or meet or exceed its financial projections and changes, (vii) the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities, (viii) the ability of Waldencast to implement its strategic initiatives and continue to innovate Obagi Medical’s and Milk Makeup’s existing products and anticipate and respond to market trends and changes in consumer preferences, (ix) any shifts in the preferences of consumers as to where and how they shop, and (x) social, political and economic conditions. These and other risks, assumptions and uncertainties are more fully described in the Risk Factors section of our 2023 20-F (File No. 01-40207), filed with the Securities and Exchange Commission (the “SEC”) on April 30, 2024, and in our other documents that we file or furnish with the SEC, which you are encouraged to read.
Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to rely on these forward-looking statements, which speak only as of the date they are made. Waldencast expressly disclaims any current intention, and assumes no duty, to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Contacts:
Investors
ICR
Allison Malkin
waldencastir@icrinc.com
Media
ICR
Brittney Fraser/Alecia Pulman
waldencast@icrinc.com
Appendix
Comparable Net Revenue Growth
Group | Obagi Medical | |||||||||||||||||||||||||||
(In thousands, except for percentages) | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||||||||||
Net Revenue | $ | 70,203 | $ | 53,683 | $ | 201,785 | $ | 163,021 | $ | 38,690 | $ | 28,167 | $ | 107,055 | $ | 85,181 | ||||||||||||
Obagi Medical China Business | 995 | 2,257 | 2,069 | 5,619 | 995 | 2,257 | 2,069 | 5,619 | ||||||||||||||||||||
Comparable Net Revenue | $ | 69,208 | $ | 51,426 | $ | 199,716 | $ | 157,402 | $ | 37,695 | $ | 25,910 | $ | 104,986 | $ | 79,562 | ||||||||||||
Comparable Growth | 34.6 | % | 26.9 | % | 45.5 | % | 32.0 | % | ||||||||||||||||||||
Adjusted Gross Profit
Group | ||||||||||||||||
(In thousands, except for percentages) | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||
Net Revenue | $ | 70,203 | $ | 53,683 | $ | 201,785 | $ | 163,021 | ||||||||
Gross Profit | $ | 48,121 | $ | 35,922 | $ | 142,294 | $ | 104,101 | ||||||||
Gross Profit Margin | 68.5 | % | 66.9 | % | 70.5 | % | 63.9 | % | ||||||||
Gross Margin Adjustments: | ||||||||||||||||
Amortization of the fair value of the related party liability(1) | (732 | ) | (1,687 | ) | (1,510 | ) | (4,058 | ) | ||||||||
Amortization of the inventory fair value adjustment(2) | — | — | — | 1,691 | ||||||||||||
Discontinued product write-off(3) | 1,200 | — | 1,726 | — | ||||||||||||
Amortization impact of intangible assets(4) | 2,801 | 2,921 | 8,404 | 8,404 | ||||||||||||
Adjusted Gross Profit | $ | 51,390 | $ | 37,155 | $ | 150,913 | $ | 110,138 | ||||||||
Adjusted Gross Margin % | 73.2 | % | 69.2 | % | 74.8 | % | 67.6 | % |
(1) | Relates to the fair value of the related party liability for the unfavorable discount to the Obagi Medical China Business as part of the Business Combination. | |
(2) | Relates to the amortization of the inventory fair value step-up as a result of the Business Combination. | |
(3) | Relates to the advanced purchase of specific products for the market in Vietnam sold through the Vietnam distributor that became obsolete when the contract was terminated. | |
(4) | The Supply Agreement and Formulations intangible assets are amortized to COGS. |
Obagi Medical | Milk Makeup | |||||||||||||||||||||||||||||||
(In thousands, except for percentages) | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||||||||||||||
Net Revenue | $ | 38,690 | $ | 28,167 | $ | 107,055 | $ | 85,181 | $ | 31,513 | $ | 25,516 | $ | 94,730 | $ | 77,840 | ||||||||||||||||
Gross Profit | $ | 27,139 | $ | 18,066 | $ | 76,710 | $ | 53,406 | $ | 20,982 | $ | 17,855 | $ | 65,590 | $ | 50,695 | ||||||||||||||||
Gross Profit Margin | 70.1 | % | 64.1 | % | 71.7 | % | 62.7 | % | 66.6 | % | 70.0 | % | 69.2 | % | 65.1 | % | ||||||||||||||||
Gross Margin Adjustments: | ||||||||||||||||||||||||||||||||
Amortization of the fair value of the related party liability | (732 | ) | (1,687 | ) | (1,510 | ) | (4,058 | ) | — | — | — | — | ||||||||||||||||||||
Amortization of the inventory fair value adjustment | — | — | — | — | — | — | — | 1,691 | ||||||||||||||||||||||||
Discontinued product write-off | 1,200 | — | 1,726 | — | — | — | — | — | ||||||||||||||||||||||||
Amortization impact of intangible assets | 2,801 | 2,921 | 8,404 | 8,404 | — | — | — | — | ||||||||||||||||||||||||
Adjusted Gross Profit | $ | 30,408 | $ | 19,300 | $ | 85,329 | $ | 57,752 | $ | 20,982 | $ | 17,855 | $ | 65,590 | $ | 52,386 | ||||||||||||||||
Adjusted Gross Margin % | 78.6 | % | 68.5 | % | 79.7 | % | 67.8 | % | 66.6 | % | 70.0 | % | 69.2 | % | 67.3 | % | ||||||||||||||||
Adjusted EBITDA Margin by Segment
Obagi Medical | Milk Makeup | |||||||||||||||||||||||||||||||
(In thousands, except for percentages) | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||||||||||||||
Net (Loss) Income | $ | (7,975 | ) | $ | (11,647 | ) | $ | (19,410 | ) | $ | (23,906 | ) | $ | 3,647 | $ | (1,050 | ) | $ | 8,573 | $ | (1,700 | ) | ||||||||||
Adjusted For: | ||||||||||||||||||||||||||||||||
Depreciation and amortization | 10,405 | 10,853 | 31,195 | 31,578 | 4,584 | 4,521 | 13,808 | 14,057 | ||||||||||||||||||||||||
Interest expense, net | 3,001 | 3,325 | 9,323 | 9,303 | (3 | ) | 162 | 2 | 586 | |||||||||||||||||||||||
Income tax expense (benefit) | (1,717 | ) | (1,498 | ) | (4,074 | ) | (6,008 | ) | 8 | — | 8 | 1 | ||||||||||||||||||||
Stock-based compensation expense | 193 | 52 | (793 | ) | 1,043 | (43 | ) | 478 | 1,506 | 1,908 | ||||||||||||||||||||||
Legal and advisory non-recurring costs | 3,238 | 583 | 3,993 | 583 | — | 27 | — | 27 | ||||||||||||||||||||||||
Amortization of related party liability | (732 | ) | (1,687 | ) | (1,510 | ) | (4,058 | ) | — | — | — | — | ||||||||||||||||||||
Other costs | 1,072 | 3,277 | 1,954 | 4,346 | 334 | 133 | 354 | 2,139 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 7,484 | $ | 3,258 | $ | 20,678 | $ | 12,882 | $ | 8,526 | $ | 4,272 | $ | 24,249 | $ | 17,016 | ||||||||||||||||
Net Revenue | $ | 38,690 | $ | 28,167 | $ | 107,055 | $ | 85,181 | $ | 31,513 | $ | 25,516 | $ | 94,730 | $ | 77,840 | ||||||||||||||||
Net (Loss) Income % of Net Revenue | (20.6 | )% | (41.4 | )% | (18.1 | )% | (28.1 | )% | 11.6 | % | (4.1 | )% | 9.0 | % | (2.2 | )% | ||||||||||||||||
Adjusted EBITDA Margin | 19.3 | % | 11.6 | % | 19.3 | % | 15.1 | % | 27.1 | % | 16.7 | % | 25.6 | % | 21.9 | % |
Central costs | ||||||||||||||||
(In thousands, except for percentages) | Three months ended September 30, 2024 | Three months ended September 30, 2023 | Nine months ended September 30, 2024 | Nine months ended September 30, 2023 | ||||||||||||
Net Loss | $ | (8,816 | ) | $ | (23,759 | ) | $ | (15,213 | ) | $ | (47,631 | ) | ||||
Adjusted For: | ||||||||||||||||
Interest expense, net | 1,357 | 1,514 | 3,742 | 4,723 | ||||||||||||
Income tax expense | 60 | 8 | 64 | 8 | ||||||||||||
Stock-based compensation expense | 1,723 | 1,549 | 5,686 | 4,608 | ||||||||||||
Legal and advisory non-recurring costs | 4,788 | 8,601 | 14,471 | 19,224 | ||||||||||||
Change in fair value of warrants and interest rate collar | (3,390 | ) | 9,437 | (24,122 | ) | 7,970 | ||||||||||
Other costs | (316 | ) | (1 | ) | (455 | ) | (18 | ) | ||||||||
Adjusted EBITDA | $ | (4,595 | ) | $ | (2,651 | ) | $ | (15,829 | ) | $ | (11,116 | ) | ||||
Net Revenue | N/A | N/A | N/A | N/A | ||||||||||||
Net Loss % of Net Revenue | N/A | N/A | N/A | N/A | ||||||||||||
Adjusted EBITDA Margin | N/A | N/A | N/A | N/A | ||||||||||||
Fully Diluted Share Count
Shares | ||||||||||
Class A Ordinary Shares Outstanding (as of November 15, 2024) | 111,818,130 | |||||||||
Class A ordinary shares subject to outstanding stock options held by our executive officers that are currently exercisable or exercisable within 60 days of the record date | 3,833,332 | |||||||||
Class A ordinary shares subject to restricted stock units that are vested or will vest within 60 days of the record date, but have not yet been settled1 | 266,246 | |||||||||
Total Class A Outstanding with Dilutive Executive Awards | 115,917,708 | |||||||||
Class B Shares Outstanding2(as of November 15, 2024) | 10,766,528 | |||||||||
Less: Dilutive Executive Shares from Above | 4,099,578 | |||||||||
Basic share outstanding | 122,584,658 | |||||||||
Vested employee RSUs1 | 266,246 | |||||||||
Basic shares outstanding | 122,850,904 | |||||||||
No. of Shares |
Weighted Avg. Strike Price | |||||||||
Unvested employee RSUs3 | 5,478,083 | |||||||||
Vested employee stock rights with exercise prices4 | 10,215,200 | $ | 11.20 | — | ||||||
Unvested employee stock rights with exercise prices4 | 8,062,239 | $ | 13.87 | — | ||||||
Total diluted shares outstanding | 128,328,987 | |||||||||
Warrants5 | $ | 11.50 | 29,533,282 |
1 | Vested RSUs included in basic shares outstanding as they have been approved but not issued. | |
2 | Waldencast plc Class B shares owned by former members of Milk Makeup. | |
3 | Unvested RSUs includes awards granted in October 2024. | |
4 | Dilution from employee stock rights with exercise prices assumes net share settlement under treasury stock method, based on WALD closing price on November 14, 2024. | |
5 | Includes 17,869,732 Waldencast plc private placement warrants. | |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.